data_2dde_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2dde _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.435 ' C ' ' HD3' ' A' ' 2' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.435 ' HD3' ' C ' ' A' ' 1' ' ' CYS . 0.0 OUTLIER -114.3 162.98 15.9 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.294 -0.879 . . . . 0.0 109.188 179.9 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.47 ' HG3' ' O ' ' A' ' 16' ' ' GLY . 2.5 tt0 . . . . . 0 N--CA 1.489 1.501 0 O-C-N 121.122 -0.986 . . . . 0.0 109.8 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.485 ' N ' ' HA ' ' A' ' 14' ' ' CYS . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . . . -99.68 -13.51 19.31 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.331 -0.856 . . . . 0.0 109.099 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.526 ' N ' ' CD1' ' A' ' 7' ' ' PHE . 0.2 OUTLIER -136.91 57.49 1.76 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.411 -0.806 . . . . 0.0 109.136 179.78 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -118.66 -175.37 16.38 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.78 -35.17 1.54 Allowed 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.624 2.216 . . . . 0.0 110.329 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 . . . . . 0 N--CA 1.489 1.502 0 O-C-N 121.314 -0.866 . . . . 0.0 109.322 179.888 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 31.0 p90 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.075 0.464 . . . . 0.0 110.041 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.51 ' O ' ' CB ' ' A' ' 14' ' ' CYS . 13.4 t -85.12 -50.49 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.041 -1.037 . . . . 0.0 109.563 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.51 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 12.5 m . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.404 -0.81 . . . . 0.0 109.168 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.47 ' O ' ' HG3' ' A' ' 3' ' ' GLN . . . . . . . . 0 N--CA 1.49 2.268 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.252 -1.146 . . . . 0.0 109.489 -179.986 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 4.4 t . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 121.173 0.511 . . . . 0.0 109.689 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.04 -162.82 0.08 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.198 -0.939 . . . . 0.0 109.189 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.459 ' O ' ' SG ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.404 0 O-C-N 121.245 -0.909 . . . . 0.0 109.809 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.509 ' N ' ' HA ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . . . -106.97 8.59 30.55 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.205 -0.935 . . . . 0.0 109.525 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.505 ' O ' ' CG ' ' A' ' 7' ' ' PHE . 4.8 p90 -139.69 39.59 2.02 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.192 -0.942 . . . . 0.0 109.748 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -121.13 170.63 14.64 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.56 -30.75 2.96 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.537 2.158 . . . . 0.0 109.964 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.492 0 O-C-N 121.361 -0.837 . . . . 0.0 109.144 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 8.4 p90 . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.085 0.469 . . . . 0.0 109.91 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.4 t -91.72 -30.39 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.277 -0.889 . . . . 0.0 109.244 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.509 ' HA ' ' N ' ' A' ' 5' ' ' CYS . 1.6 m . . . . . 0 N--CA 1.492 1.648 0 O-C-N 121.324 -0.86 . . . . 0.0 109.916 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.301 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 4.8 t30 . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.347 -1.09 . . . . 0.0 109.473 179.919 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.411 ' NE ' ' HA ' ' A' ' 2' ' ' ARG . 1.5 mmp_? -67.25 108.4 2.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.334 -0.854 . . . . 0.0 109.653 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.43 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.304 -1.407 0 O-C-N 121.334 -0.854 . . . . 0.0 109.403 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.258 0.551 . . . . 0.0 109.527 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . . . -113.64 -6.91 13.35 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.282 -0.887 . . . . 0.0 109.424 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.491 ' CZ ' ' HA3' ' A' ' 16' ' ' GLY . 0.2 OUTLIER -132.41 43.07 3.04 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.291 -0.881 . . . . 0.0 109.453 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -127.5 147.33 17.04 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -77.38 -3.62 13.85 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.545 2.163 . . . . 0.0 110.58 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.57 ' HB3' ' CD2' ' A' ' 12' ' ' PHE . 26.3 m-85 . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.198 -0.939 . . . . 0.0 109.292 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.57 ' CD2' ' HB3' ' A' ' 10' ' ' PHE . 34.0 p90 . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.469 ' O ' ' CB ' ' A' ' 14' ' ' CYS . 96.8 t -81.94 -55.54 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.235 -0.916 . . . . 0.0 109.294 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.469 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 1.3 m . . . . . 0 N--CA 1.489 1.503 0 O-C-N 121.277 -0.889 . . . . 0.0 109.509 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.491 ' HA3' ' CZ ' ' A' ' 7' ' ' PHE . . . . . . . . 0 N--CA 1.49 2.255 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.219 -1.165 . . . . 0.0 109.595 -179.889 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 7.1 t . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.245 0.545 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.24 161.99 18.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.319 -0.863 . . . . 0.0 109.31 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.473 ' HG3' ' O ' ' A' ' 3' ' ' GLN . 6.7 pt20 . . . . . 0 N--CA 1.489 1.505 0 O-C-N 121.228 -0.92 . . . . 0.0 109.593 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.407 ' SG ' ' O ' ' A' ' 5' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . . . -99.94 -45.5 5.67 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.201 -0.937 . . . . 0.0 109.672 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.549 ' O ' ' CG ' ' A' ' 7' ' ' PHE . 35.5 p90 -135.33 116.78 14.71 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.226 -0.921 . . . . 0.0 109.447 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -169.82 173.26 43.97 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.0 -34.7 1.61 Allowed 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.599 2.199 . . . . 0.0 110.315 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.196 -0.94 . . . . 0.0 109.255 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 2.1 p90 . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 80.8 t -114.42 107.72 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.285 -0.884 . . . . 0.0 109.33 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.468 ' SG ' ' O ' ' A' ' 3' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.531 0 O-C-N 121.426 -0.797 . . . . 0.0 109.523 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.41 ' O ' ' CB ' ' A' ' 3' ' ' GLN . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.274 -1.133 . . . . 0.0 109.575 -179.888 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.443 ' O ' ' HG2' ' A' ' 3' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.69 120.22 13.12 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.206 -0.934 . . . . 0.0 108.843 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.493 ' HB3' ' O ' ' A' ' 16' ' ' GLY . 1.2 mt-30 . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.183 -0.948 . . . . 0.0 109.866 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.536 ' N ' ' HA ' ' A' ' 14' ' ' CYS . 23.6 t . . . . . 0 N--CA 1.489 1.491 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . . . -107.02 -34.24 7.24 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.288 -0.883 . . . . 0.0 109.739 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.449 ' O ' ' CD2' ' A' ' 7' ' ' PHE . 48.5 p90 -104.64 30.78 5.16 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.113 -0.992 . . . . 0.0 109.684 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -103.45 145.38 16.18 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -76.75 -12.54 18.15 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.434 2.089 . . . . 0.0 110.3 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 . . . . . 0 N--CA 1.489 1.481 0 O-C-N 121.126 -0.984 . . . . 0.0 109.058 179.596 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.432 ' CD1' ' C ' ' A' ' 12' ' ' PHE . 13.8 p90 . . . . . 0 N--CA 1.492 1.673 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.53 ' O ' ' CB ' ' A' ' 14' ' ' CYS . 96.8 t -60.7 -56.37 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.168 -0.957 . . . . 0.0 109.593 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.536 ' HA ' ' N ' ' A' ' 5' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 O-C-N 121.507 -0.746 . . . . 0.0 109.42 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.493 ' O ' ' HB3' ' A' ' 3' ' ' GLN . . . . . . . . 0 N--CA 1.491 2.361 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.5 t30 . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.09 -1.241 . . . . 0.0 109.703 179.813 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.439 ' SG ' ' ND2' ' A' ' 17' ' ' ASN . 1.5 p . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.32 0.581 . . . . 0.0 109.502 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.513 ' HD3' ' N ' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -104.75 142.77 34.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.288 -0.882 . . . . 0.0 109.061 179.849 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.465 ' HB3' ' O ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.509 0 O-C-N 121.178 -0.951 . . . . 0.0 109.842 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.526 ' N ' ' HA ' ' A' ' 14' ' ' CYS . 15.9 t . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.27 0.557 . . . . 0.0 109.8 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . . . -120.61 -33.11 3.89 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.327 -0.858 . . . . 0.0 109.313 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -118.48 45.35 2.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.262 -0.899 . . . . 0.0 109.462 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -104.13 158.41 16.8 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.52 -18.45 13.75 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.544 2.163 . . . . 0.0 110.418 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.285 -0.884 . . . . 0.0 109.32 179.727 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 10.9 p90 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.235 0.541 . . . . 0.0 109.563 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.7 t -53.66 -31.78 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.275 -0.891 . . . . 0.0 109.323 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.526 ' HA ' ' N ' ' A' ' 5' ' ' CYS . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 O-C-N 121.355 -0.84 . . . . 0.0 109.634 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.465 ' O ' ' HB3' ' A' ' 3' ' ' GLN . . . . . . . . 0 N--CA 1.49 2.271 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.439 ' ND2' ' SG ' ' A' ' 1' ' ' CYS . 26.5 t30 . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.175 -1.191 . . . . 0.0 109.72 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.288 0.566 . . . . 0.0 109.495 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.2 mtm180 -142.47 95.02 2.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -0.901 . . . . 0.0 109.259 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.474 ' O ' ' O ' ' A' ' 16' ' ' GLY . 1.4 tt0 . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.063 -1.023 . . . . 0.0 109.244 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.417 ' N ' ' HA ' ' A' ' 14' ' ' CYS . 44.3 t . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 121.362 0.601 . . . . 0.0 109.435 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . . . -108.99 2.19 21.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.299 -0.876 . . . . 0.0 109.615 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.452 ' CD1' ' C ' ' A' ' 7' ' ' PHE . 8.7 p90 -125.61 -14.12 6.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.112 -0.992 . . . . 0.0 109.912 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -67.2 162.37 46.73 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.18 -19.31 12.13 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.582 2.188 . . . . 0.0 110.519 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.214 -0.929 . . . . 0.0 109.613 -179.803 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 27.4 p90 . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 121.155 0.502 . . . . 0.0 110.196 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.464 ' O ' ' CB ' ' A' ' 14' ' ' CYS . 40.6 t -95.21 -43.79 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.173 -0.954 . . . . 0.0 109.362 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.464 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.703 0 O-C-N 121.229 -0.92 . . . . 0.0 109.452 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 3' ' ' GLN . . . . . . . . 0 N--CA 1.492 2.405 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 O-C-N 121.248 -1.148 . . . . 0.0 109.291 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 26.7 p . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -102.52 137.13 41.16 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.162 -0.961 . . . . 0.0 109.717 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.505 0 O-C-N 121.409 -0.807 . . . . 0.0 109.407 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.554 ' CB ' ' HA ' ' A' ' 14' ' ' CYS . 36.3 t . . . . . 0 N--CA 1.494 1.765 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . . . -118.93 -5.35 10.58 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.193 -0.942 . . . . 0.0 109.714 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -129.52 19.02 5.75 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.161 -0.962 . . . . 0.0 109.727 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -93.28 162.45 25.88 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.32 -21.03 10.71 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.689 2.259 . . . . 0.0 110.573 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.111 -0.993 . . . . 0.0 109.792 -179.702 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.9 p90 . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.274 0.559 . . . . 0.0 109.628 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.407 ' O ' ' C ' ' A' ' 14' ' ' CYS . 11.5 t -70.88 -23.42 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.26 -0.9 . . . . 0.0 109.333 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.554 ' HA ' ' CB ' ' A' ' 5' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.394 -0.816 . . . . 0.0 110.015 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.219 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.35 -1.088 . . . . 0.0 109.305 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 15.8 p . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 121.359 0.6 . . . . 0.0 109.439 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -78.3 141.45 38.48 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.22 -0.925 . . . . 0.0 109.341 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.462 0 O-C-N 121.312 -0.867 . . . . 0.0 109.463 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.496 ' CB ' ' HA ' ' A' ' 14' ' ' CYS . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . . . -119.84 -25.96 5.74 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.156 -0.965 . . . . 0.0 109.579 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -128.72 66.97 1.4 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.195 -0.941 . . . . 0.0 109.718 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -120.66 174.15 15.64 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.2 -19.13 12.24 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.693 2.262 . . . . 0.0 110.396 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.284 -0.885 . . . . 0.0 109.39 -179.958 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 21.5 p90 . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.252 0.548 . . . . 0.0 109.648 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 74.4 t -61.2 -49.66 83.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.167 -0.958 . . . . 0.0 109.257 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.496 ' HA ' ' CB ' ' A' ' 5' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.361 -0.837 . . . . 0.0 109.948 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.186 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 61.4 t30 . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.227 -1.161 . . . . 0.0 109.45 -179.928 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 12.9 mtm180 57.36 -167.27 0.13 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.218 -0.926 . . . . 0.0 109.003 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.456 ' O ' ' SG ' ' A' ' 14' ' ' CYS . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.095 -1.003 . . . . 0.0 109.739 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 51.1 t . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 121.247 0.546 . . . . 0.0 109.593 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . . . -102.04 -58.01 1.96 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.191 -0.943 . . . . 0.0 109.512 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -119.11 132.68 56.02 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.278 -0.889 . . . . 0.0 109.468 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.97 167.71 22.81 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.426 -1.469 . . . . 0.0 109.426 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.03 -10.1 17.97 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.616 2.211 . . . . 0.0 110.401 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.243 -0.91 . . . . 0.0 109.419 179.821 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 43.9 p90 . . . . . 0 N--CA 1.492 1.668 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.454 ' O ' ' O ' ' A' ' 14' ' ' CYS . 16.6 t -121.64 -13.67 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.154 -0.966 . . . . 0.0 109.676 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.456 ' SG ' ' O ' ' A' ' 3' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 O-C-N 121.198 -0.939 . . . . 0.0 109.078 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.408 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 12.0 t30 . . . . . 0 N--CA 1.488 1.457 0 O-C-N 121.382 -1.069 . . . . 0.0 109.526 -179.936 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.435 ' C ' ' HD3' ' A' ' 2' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.435 ' HD3' ' C ' ' A' ' 1' ' ' CYS . 0.0 OUTLIER -114.3 162.98 15.9 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.294 -0.879 . . . . 0.0 109.188 179.9 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.585 ' O ' ' CB ' ' A' ' 4' ' ' DAL . 2.5 tt0 -117.29 113.34 22.02 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.122 -0.986 . . . . 0.0 109.8 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' DAL . . . . . 0.585 ' CB ' ' O ' ' A' ' 3' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.485 ' N ' ' HA ' ' A' ' 14' ' ' CYS . 0.1 OUTLIER 60.77 103.11 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.206 -0.934 . . . . 0.0 109.4 -179.962 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . . . -99.68 -13.51 19.31 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.331 -0.856 . . . . 0.0 109.099 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.526 ' N ' ' CD1' ' A' ' 7' ' ' PHE . 0.2 OUTLIER -136.91 57.49 1.76 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.411 -0.806 . . . . 0.0 109.136 179.78 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -118.66 -175.37 16.38 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.78 -35.17 1.54 Allowed 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.624 2.216 . . . . 0.0 110.329 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -120.24 -74.97 0.59 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.314 -0.866 . . . . 0.0 109.322 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -135.68 0.62 2.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.821 -1.175 . . . . 0.0 110.041 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.51 ' O ' ' CB ' ' A' ' 14' ' ' CYS . 13.4 t -85.12 -50.49 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.041 -1.037 . . . . 0.0 109.563 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.51 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 12.5 m 78.49 79.29 0.06 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.404 -0.81 . . . . 0.0 109.168 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' BH2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.47 ' O ' ' HG3' ' A' ' 3' ' ' GLN . . . 179.79 173.97 45.3 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -135.47 173.18 12.01 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.252 -1.146 . . . . 0.0 109.489 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.361 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LSP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 4.4 t . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 121.173 0.511 . . . . 0.0 109.689 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.04 -162.82 0.08 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.198 -0.939 . . . . 0.0 109.189 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.582 ' O ' ' CB ' ' A' ' 4' ' ' DAL . 0.0 OUTLIER -140.72 122.74 15.59 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.245 -0.909 . . . . 0.0 109.809 179.712 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' DAL . . . . . 0.582 ' CB ' ' O ' ' A' ' 3' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.509 ' N ' ' HA ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER 50.72 91.5 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.106 -0.996 . . . . 0.0 109.347 179.845 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . . . -106.97 8.59 30.55 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.205 -0.935 . . . . 0.0 109.525 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.505 ' O ' ' CG ' ' A' ' 7' ' ' PHE . 4.8 p90 -139.69 39.59 2.02 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.192 -0.942 . . . . 0.0 109.748 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -121.13 170.63 14.64 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.413 ' HD2' ' H11' ' A' ' 100' ' ' LSP . 35.6 Cg_endo -78.56 -30.75 2.96 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.537 2.158 . . . . 0.0 109.964 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -100.14 -80.87 0.47 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.361 -0.837 . . . . 0.0 109.144 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' DBB . . . . . 0.459 ' HB2' ' O ' ' A' ' 5' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -138.23 6.24 2.57 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.938 -1.101 . . . . 0.0 109.91 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.482 ' CG2' ' H2 ' ' A' ' 100' ' ' LSP . 3.4 t -91.72 -30.39 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.277 -0.889 . . . . 0.0 109.244 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.509 ' HA ' ' N ' ' A' ' 5' ' ' CYS . 1.6 m 56.62 82.85 0.11 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.324 -0.86 . . . . 0.0 109.916 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' BH2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.22 149.85 23.27 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -101.4 73.62 1.49 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.347 -1.09 . . . . 0.0 109.473 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.456 ' OXT' ' HA ' ' A' ' 3' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.295 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LSP . . . . . 0.482 ' H2 ' ' CG2' ' A' ' 13' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.472 ' SG ' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.411 ' NE ' ' HA ' ' A' ' 2' ' ' ARG . 1.5 mmp_? -67.25 108.4 2.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.334 -0.854 . . . . 0.0 109.653 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.613 ' O ' ' CB ' ' A' ' 4' ' ' DAL . 0.0 OUTLIER -107.58 40.05 1.79 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.334 -0.854 . . . . 0.0 109.403 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' DAL . . . . . 0.613 ' CB ' ' O ' ' A' ' 3' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.771 ' HB2' ' HN3' ' A' ' 100' ' ' LSP . 0.7 OUTLIER 67.66 99.83 0.05 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.355 -0.841 . . . . 0.0 109.527 -179.842 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . . . -113.64 -6.91 13.35 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.282 -0.887 . . . . 0.0 109.424 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.491 ' CZ ' ' HA3' ' A' ' 16' ' ' GLY . 0.2 OUTLIER -132.41 43.07 3.04 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.291 -0.881 . . . . 0.0 109.453 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -127.5 147.33 17.04 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -77.38 -3.62 13.85 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.545 2.163 . . . . 0.0 110.58 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.57 ' HB3' ' CD2' ' A' ' 12' ' ' PHE . 26.3 m-85 -101.46 -80.56 0.5 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.198 -0.939 . . . . 0.0 109.292 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.57 ' CD2' ' HB3' ' A' ' 10' ' ' PHE . 34.0 p90 -120.84 -4.16 9.67 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.27 -0.894 . . . . 0.0 109.23 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.469 ' O ' ' CB ' ' A' ' 14' ' ' CYS . 96.8 t -81.94 -55.54 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.235 -0.916 . . . . 0.0 109.294 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.469 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 1.3 m 73.24 74.16 0.13 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.277 -0.889 . . . . 0.0 109.509 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' BH2 . . . . . 0.404 ' H1N' ' HN1' ' A' ' 100' ' ' LSP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.491 ' HA3' ' CZ ' ' A' ' 7' ' ' PHE . . . -109.0 117.22 4.87 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -138.16 117.89 13.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.219 -1.165 . . . . 0.0 109.595 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.479 ' HD2' ' CE2' ' A' ' 7' ' ' PHE . 33.9 mtpt . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.417 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LSP . . . . . 0.771 ' HN3' ' HB2' ' A' ' 5' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 7.1 t . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.245 0.545 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.418 ' C ' ' OXT' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -116.24 161.99 18.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.319 -0.863 . . . . 0.0 109.31 179.896 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.576 ' O ' ' CB ' ' A' ' 4' ' ' DAL . 6.7 pt20 -134.96 101.01 4.75 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.228 -0.92 . . . . 0.0 109.593 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' DAL . . . . . 0.576 ' CB ' ' O ' ' A' ' 3' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.447 ' HB2' ' HG3' ' A' ' 11' ' ' DBB . 0.0 OUTLIER -75.42 106.98 7.24 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.258 -0.901 . . . . 0.0 109.237 179.894 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.418 ' HB2' ' HB3' ' A' ' 19' ' ' LYS . . . -99.94 -45.5 5.67 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.201 -0.937 . . . . 0.0 109.672 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.549 ' O ' ' CG ' ' A' ' 7' ' ' PHE . 35.5 p90 -135.33 116.78 14.71 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.226 -0.921 . . . . 0.0 109.447 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -169.82 173.26 43.97 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.0 -34.7 1.61 Allowed 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.599 2.199 . . . . 0.0 110.315 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -100.0 -83.64 0.43 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.196 -0.94 . . . . 0.0 109.255 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' DBB . . . . . 0.447 ' HG3' ' HB2' ' A' ' 5' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -140.52 12.45 2.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.956 -1.09 . . . . 0.0 109.189 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.471 ' CG2' ' H2 ' ' A' ' 100' ' ' LSP . 80.8 t -114.42 107.72 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.285 -0.884 . . . . 0.0 109.33 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.468 ' SG ' ' O ' ' A' ' 3' ' ' GLN . 0.0 OUTLIER -58.58 151.48 20.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.426 -0.797 . . . . 0.0 109.523 -179.796 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' BH2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.41 ' O ' ' CB ' ' A' ' 3' ' ' GLN . . . 150.47 -131.67 3.66 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -110.34 143.23 40.87 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.274 -1.133 . . . . 0.0 109.575 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.491 ' NZ ' ' CB ' ' A' ' 19' ' ' LYS . 7.4 mtpm? . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 117.987 -1.006 . . . . 0.0 109.486 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LSP . . . . . 0.471 ' H2 ' ' CG2' ' A' ' 13' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.443 ' O ' ' HG2' ' A' ' 3' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.69 120.22 13.12 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.206 -0.934 . . . . 0.0 108.843 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.606 ' O ' ' CB ' ' A' ' 4' ' ' DAL . 1.2 mt-30 -125.66 91.56 3.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.183 -0.948 . . . . 0.0 109.866 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' DAL . . . . . 0.606 ' CB ' ' O ' ' A' ' 3' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.536 ' N ' ' HA ' ' A' ' 14' ' ' CYS . 23.6 t 75.03 84.48 0.1 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.252 -0.905 . . . . 0.0 109.111 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . . . -107.02 -34.24 7.24 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.288 -0.883 . . . . 0.0 109.739 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.534 ' CE2' H112 ' A' ' 100' ' ' LSP . 48.5 p90 -104.64 30.78 5.16 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.113 -0.992 . . . . 0.0 109.684 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -103.45 145.38 16.18 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -76.75 -12.54 18.15 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.434 2.089 . . . . 0.0 110.3 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -109.0 -72.65 0.72 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.126 -0.984 . . . . 0.0 109.058 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.432 ' CD1' ' C ' ' A' ' 12' ' ' PHE . 13.8 p90 -127.42 -29.65 2.68 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.124 -0.985 . . . . 0.0 109.627 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.53 ' O ' ' CB ' ' A' ' 14' ' ' CYS . 96.8 t -60.7 -56.37 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.168 -0.957 . . . . 0.0 109.593 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.536 ' HA ' ' N ' ' A' ' 5' ' ' CYS . 0.0 OUTLIER 77.73 79.36 0.07 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.507 -0.746 . . . . 0.0 109.42 -179.793 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' BH2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.493 ' O ' ' HB3' ' A' ' 3' ' ' GLN . . . -82.01 143.27 23.0 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -141.4 68.17 1.34 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.09 -1.241 . . . . 0.0 109.703 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.033 -1.042 . . . . 0.0 109.394 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LSP . . . . . 0.534 H112 ' CE2' ' A' ' 7' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.439 ' SG ' ' ND2' ' A' ' 17' ' ' ASN . 1.5 p . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.32 0.581 . . . . 0.0 109.502 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.513 ' HD3' ' N ' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -104.75 142.77 34.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.288 -0.882 . . . . 0.0 109.061 179.849 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.61 ' O ' ' CB ' ' A' ' 4' ' ' DAL . 0.0 OUTLIER -140.23 114.74 9.35 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.178 -0.951 . . . . 0.0 109.842 -179.827 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' DAL . . . . . 0.61 ' CB ' ' O ' ' A' ' 3' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.526 ' N ' ' HA ' ' A' ' 14' ' ' CYS . 15.9 t 75.08 111.82 0.07 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.194 -0.941 . . . . 0.0 109.8 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . . . -120.61 -33.11 3.89 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.327 -0.858 . . . . 0.0 109.313 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.508 ' CD1' H112 ' A' ' 100' ' ' LSP . 2.2 p90 -118.48 45.35 2.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.262 -0.899 . . . . 0.0 109.462 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.417 ' HA2' H111 ' A' ' 100' ' ' LSP . . . -104.13 158.41 16.8 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.52 -18.45 13.75 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.544 2.163 . . . . 0.0 110.418 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -113.16 -67.25 1.01 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.285 -0.884 . . . . 0.0 109.32 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -113.54 -25.58 8.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.034 -1.041 . . . . 0.0 109.563 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.7 t -53.66 -31.78 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.275 -0.891 . . . . 0.0 109.323 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.536 ' HA ' ' C ' ' A' ' 4' ' ' DAL . 0.9 OUTLIER 53.38 71.72 0.48 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.355 -0.84 . . . . 0.0 109.634 179.785 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' BH2 . . . . . 0.449 ' O ' ' OB ' ' A' ' 15' ' ' BH2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.465 ' O ' ' HB3' ' A' ' 3' ' ' GLN . . . -176.74 -170.5 39.34 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.439 ' ND2' ' SG ' ' A' ' 1' ' ' CYS . 26.5 t30 -140.19 141.21 35.99 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.175 -1.191 . . . . 0.0 109.72 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 3' ' ' GLN . 6.2 mtmt . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 118.028 -0.986 . . . . 0.0 109.532 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LSP . . . . . 0.508 H112 ' CD1' ' A' ' 7' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.288 0.566 . . . . 0.0 109.495 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.457 ' O ' ' HG3' ' A' ' 19' ' ' LYS . 7.2 mtm180 -142.47 95.02 2.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -0.901 . . . . 0.0 109.259 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.601 ' O ' ' CB ' ' A' ' 4' ' ' DAL . 1.4 tt0 -99.52 62.04 1.2 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.063 -1.023 . . . . 0.0 109.244 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' DAL . . . . . 0.601 ' CB ' ' O ' ' A' ' 3' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.534 ' CB ' ' O ' ' A' ' 4' ' ' DAL . 44.3 t 79.33 73.24 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.536 -0.727 . . . . 0.0 109.435 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . . . -108.99 2.19 21.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.299 -0.876 . . . . 0.0 109.615 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.452 ' CD1' ' C ' ' A' ' 7' ' ' PHE . 8.7 p90 -125.61 -14.12 6.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.112 -0.992 . . . . 0.0 109.912 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -67.2 162.37 46.73 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.18 -19.31 12.13 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.582 2.188 . . . . 0.0 110.519 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -106.64 -86.64 0.48 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.214 -0.929 . . . . 0.0 109.613 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -128.34 8.07 5.96 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.62 -1.3 . . . . 0.0 110.196 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.464 ' O ' ' CB ' ' A' ' 14' ' ' CYS . 40.6 t -95.21 -43.79 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.173 -0.954 . . . . 0.0 109.362 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.464 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 0.5 OUTLIER 72.77 125.91 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.229 -0.92 . . . . 0.0 109.452 179.891 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' BH2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 3' ' ' GLN . . . 169.93 -137.05 4.28 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -139.1 143.26 38.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.248 -1.148 . . . . 0.0 109.291 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' DBB . . . . . 0.406 ' N ' ' HB2' ' A' ' 3' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.459 ' HG3' ' HA ' ' A' ' 3' ' ' GLN . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.078 -1.014 . . . . 0.0 109.446 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LSP . . . . . 0.425 ' H11' ' CG2' ' A' ' 13' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 26.7 p . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.513 ' HB2' ' CD ' ' A' ' 19' ' ' LYS . 2.6 mmp_? -102.52 137.13 41.16 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.162 -0.961 . . . . 0.0 109.717 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.598 ' O ' ' CB ' ' A' ' 4' ' ' DAL . 0.0 OUTLIER -119.83 60.09 0.86 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.409 -0.807 . . . . 0.0 109.407 -179.972 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' DAL . . . . . 0.598 ' CB ' ' O ' ' A' ' 3' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.554 ' CB ' ' HA ' ' A' ' 14' ' ' CYS . 36.3 t 73.88 91.74 0.08 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.336 -0.853 . . . . 0.0 109.546 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . . . -118.93 -5.35 10.58 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.193 -0.942 . . . . 0.0 109.714 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -129.52 19.02 5.75 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.161 -0.962 . . . . 0.0 109.727 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -93.28 162.45 25.88 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.32 -21.03 10.71 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.689 2.259 . . . . 0.0 110.573 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -105.48 -54.58 2.46 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.111 -0.993 . . . . 0.0 109.792 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -100.9 -10.33 20.75 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.185 -0.947 . . . . 0.0 109.628 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.458 ' CG2' ' H2 ' ' A' ' 100' ' ' LSP . 11.5 t -70.88 -23.42 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.26 -0.9 . . . . 0.0 109.333 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.556 ' HA ' ' C ' ' A' ' 4' ' ' DAL . 0.0 OUTLIER 43.66 65.04 1.08 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.394 -0.816 . . . . 0.0 110.015 -179.911 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' BH2 . . . . . 0.46 ' O ' ' OB ' ' A' ' 15' ' ' BH2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -154.89 124.07 1.46 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -121.36 34.84 5.06 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.35 -1.088 . . . . 0.0 109.305 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.513 ' CD ' ' HB2' ' A' ' 2' ' ' ARG . 7.8 mtpp . . . . . 0 N--CA 1.49 1.554 0 O-C-N 120.967 -1.083 . . . . 0.0 109.536 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LSP . . . . . 0.458 ' H2 ' ' CG2' ' A' ' 13' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 15.8 p . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 121.359 0.6 . . . . 0.0 109.439 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.429 ' O ' ' C ' ' A' ' 19' ' ' LYS . 2.7 mmp_? -78.3 141.45 38.48 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.22 -0.925 . . . . 0.0 109.341 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.6 ' O ' ' CB ' ' A' ' 4' ' ' DAL . 0.4 OUTLIER -138.84 103.64 4.87 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.312 -0.867 . . . . 0.0 109.463 -179.769 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' DAL . . . . . 0.6 ' CB ' ' O ' ' A' ' 3' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.52 ' CB ' ' O ' ' A' ' 4' ' ' DAL . 0.5 OUTLIER 75.65 111.1 0.07 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.153 -0.967 . . . . 0.0 109.184 -179.646 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . . . -119.84 -25.96 5.74 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.156 -0.965 . . . . 0.0 109.579 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -128.72 66.97 1.4 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.195 -0.941 . . . . 0.0 109.718 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -120.66 174.15 15.64 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.2 -19.13 12.24 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.693 2.262 . . . . 0.0 110.396 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -134.8 -55.58 0.83 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.284 -0.885 . . . . 0.0 109.39 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' DBB . . . . . 0.415 ' HG2' ' HB2' ' A' ' 5' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -116.34 -21.06 9.47 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.145 -0.972 . . . . 0.0 109.648 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.402 ' CG2' ' H2 ' ' A' ' 100' ' ' LSP . 74.4 t -61.2 -49.66 83.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.167 -0.958 . . . . 0.0 109.257 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.496 ' HA ' ' CB ' ' A' ' 5' ' ' CYS . 0.0 OUTLIER 69.49 45.9 0.78 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.361 -0.837 . . . . 0.0 109.948 179.685 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' BH2 . . . . . 0.426 ' HOB' ' HN2' ' A' ' 100' ' ' LSP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -106.87 159.47 14.72 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -133.38 126.9 32.29 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.227 -1.161 . . . . 0.0 109.45 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 2' ' ' ARG . 6.1 mtmp? . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 117.947 -1.025 . . . . 0.0 109.552 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LSP . . . . . 0.426 ' HN2' ' HOB' ' A' ' 15' ' ' BH2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.449 ' O ' ' OXT' ' A' ' 19' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 12.9 mtm180 57.36 -167.27 0.13 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.218 -0.926 . . . . 0.0 109.003 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.584 ' O ' ' CB ' ' A' ' 4' ' ' DAL . 0.8 OUTLIER -139.55 111.42 7.34 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.095 -1.003 . . . . 0.0 109.739 -179.755 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' DAL . . . . . 0.584 ' CB ' ' O ' ' A' ' 3' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.519 ' CB ' ' C ' ' A' ' 11' ' ' DBB . 51.1 t -68.16 108.9 3.32 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.224 -0.922 . . . . 0.0 109.593 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.451 ' HB2' ' HB3' ' A' ' 19' ' ' LYS . . . -102.04 -58.01 1.96 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.191 -0.943 . . . . 0.0 109.512 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -119.11 132.68 56.02 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.278 -0.889 . . . . 0.0 109.468 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.97 167.71 22.81 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.426 -1.469 . . . . 0.0 109.426 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.03 -10.1 17.97 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.616 2.211 . . . . 0.0 110.401 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -106.05 -90.43 0.42 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.243 -0.91 . . . . 0.0 109.419 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' DBB . . . . . 0.519 ' C ' ' CB ' ' A' ' 5' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -139.94 37.45 1.96 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.125 -0.985 . . . . 0.0 109.523 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.454 ' O ' ' O ' ' A' ' 14' ' ' CYS . 16.6 t -121.64 -13.67 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.154 -0.966 . . . . 0.0 109.676 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.456 ' SG ' ' O ' ' A' ' 3' ' ' GLN . 0.0 OUTLIER 60.77 147.73 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.198 -0.939 . . . . 0.0 109.078 -179.755 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' BH2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 170.89 -155.05 23.99 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -102.09 149.95 23.74 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.382 -1.069 . . . . 0.0 109.526 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.451 ' HB3' ' HB2' ' A' ' 6' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 117.908 -1.044 . . . . 0.0 109.587 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LSP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.428 ' C ' ' HD3' ' A' ' 2' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.428 ' HD3' ' C ' ' A' ' 1' ' ' CYS . 0.0 OUTLIER -114.3 162.98 15.9 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.294 -0.879 . . . . 0.0 109.188 179.9 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.494 ' HG3' ' O ' ' A' ' 16' ' ' GLY . 2.5 tt0 . . . . . 0 N--CA 1.489 1.501 0 O-C-N 121.122 -0.986 . . . . 0.0 109.8 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.77 ' HG ' ' N ' ' A' ' 12' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . . . -99.68 -13.51 19.31 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.331 -0.856 . . . . 0.0 109.099 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.526 ' N ' ' CD1' ' A' ' 7' ' ' PHE . 0.2 OUTLIER -136.91 57.49 1.76 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.411 -0.806 . . . . 0.0 109.136 179.78 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -118.66 -175.37 16.38 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.78 -35.17 1.54 Allowed 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.624 2.216 . . . . 0.0 110.329 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 . . . . . 0 N--CA 1.489 1.502 0 O-C-N 121.314 -0.866 . . . . 0.0 109.322 179.888 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.77 ' N ' ' HG ' ' A' ' 5' ' ' CYS . 31.0 p90 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.075 0.464 . . . . 0.0 110.041 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.804 ' O ' ' HB2' ' A' ' 14' ' ' CYS . 13.4 t -85.12 -50.49 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.041 -1.037 . . . . 0.0 109.563 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.804 ' HB2' ' O ' ' A' ' 13' ' ' VAL . 12.5 m . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.404 -0.81 . . . . 0.0 109.168 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.494 ' O ' ' HG3' ' A' ' 3' ' ' GLN . . . . . . . . 0 N--CA 1.49 2.268 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.252 -1.146 . . . . 0.0 109.489 -179.986 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 4.4 t . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 121.173 0.511 . . . . 0.0 109.689 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.04 -162.82 0.08 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.198 -0.939 . . . . 0.0 109.189 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.431 ' O ' ' SG ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.404 0 O-C-N 121.245 -0.909 . . . . 0.0 109.809 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.718 ' HG ' ' N ' ' A' ' 12' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . . . -106.97 8.59 30.55 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.205 -0.935 . . . . 0.0 109.525 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.505 ' O ' ' CG ' ' A' ' 7' ' ' PHE . 4.8 p90 -139.69 39.59 2.02 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.192 -0.942 . . . . 0.0 109.748 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -121.13 170.63 14.64 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.56 -30.75 2.96 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.537 2.158 . . . . 0.0 109.964 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.492 0 O-C-N 121.361 -0.837 . . . . 0.0 109.144 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.718 ' N ' ' HG ' ' A' ' 5' ' ' CYS . 8.4 p90 . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.085 0.469 . . . . 0.0 109.91 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.4 t -91.72 -30.39 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.277 -0.889 . . . . 0.0 109.244 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.517 ' HA ' ' N ' ' A' ' 5' ' ' CYS . 1.6 m . . . . . 0 N--CA 1.492 1.648 0 O-C-N 121.324 -0.86 . . . . 0.0 109.916 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.301 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 4.8 t30 . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.347 -1.09 . . . . 0.0 109.473 179.919 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.424 ' NE ' ' HA ' ' A' ' 2' ' ' ARG . 1.5 mmp_? -67.25 108.4 2.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.334 -0.854 . . . . 0.0 109.653 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.442 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.304 -1.407 0 O-C-N 121.334 -0.854 . . . . 0.0 109.403 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.851 ' HB3' ' HA ' ' A' ' 14' ' ' CYS . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.258 0.551 . . . . 0.0 109.527 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . . . -113.64 -6.91 13.35 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.282 -0.887 . . . . 0.0 109.424 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.518 ' CZ ' ' HA3' ' A' ' 16' ' ' GLY . 0.2 OUTLIER -132.41 43.07 3.04 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.291 -0.881 . . . . 0.0 109.453 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -127.5 147.33 17.04 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -77.38 -3.62 13.85 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.545 2.163 . . . . 0.0 110.58 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.58 ' HB3' ' CD2' ' A' ' 12' ' ' PHE . 26.3 m-85 . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.198 -0.939 . . . . 0.0 109.292 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.58 ' CD2' ' HB3' ' A' ' 10' ' ' PHE . 34.0 p90 . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.686 ' O ' ' HB2' ' A' ' 14' ' ' CYS . 96.8 t -81.94 -55.54 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.235 -0.916 . . . . 0.0 109.294 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.851 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 1.3 m . . . . . 0 N--CA 1.489 1.503 0 O-C-N 121.277 -0.889 . . . . 0.0 109.509 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.518 ' HA3' ' CZ ' ' A' ' 7' ' ' PHE . . . . . . . . 0 N--CA 1.49 2.255 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.6 t30 . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.219 -1.165 . . . . 0.0 109.595 -179.889 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 7.1 t . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.245 0.545 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.24 161.99 18.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.319 -0.863 . . . . 0.0 109.31 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.468 ' HG3' ' O ' ' A' ' 3' ' ' GLN . 6.7 pt20 . . . . . 0 N--CA 1.489 1.505 0 O-C-N 121.228 -0.92 . . . . 0.0 109.593 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.407 ' SG ' ' O ' ' A' ' 5' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . . . -99.94 -45.5 5.67 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.201 -0.937 . . . . 0.0 109.672 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.549 ' O ' ' CG ' ' A' ' 7' ' ' PHE . 35.5 p90 -135.33 116.78 14.71 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.226 -0.921 . . . . 0.0 109.447 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -169.82 173.26 43.97 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.0 -34.7 1.61 Allowed 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.599 2.199 . . . . 0.0 110.315 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.196 -0.94 . . . . 0.0 109.255 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.485 ' CE1' HG23 ' A' ' 13' ' ' VAL . 2.1 p90 . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.485 HG23 ' CE1' ' A' ' 12' ' ' PHE . 80.8 t -114.42 107.72 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.285 -0.884 . . . . 0.0 109.33 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.468 ' SG ' ' O ' ' A' ' 3' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.531 0 O-C-N 121.426 -0.797 . . . . 0.0 109.523 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.41 ' O ' ' CB ' ' A' ' 3' ' ' GLN . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.274 -1.133 . . . . 0.0 109.575 -179.888 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.465 ' O ' ' HG2' ' A' ' 3' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.418 ' CD ' ' H ' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -66.69 120.22 13.12 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.206 -0.934 . . . . 0.0 108.843 179.64 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.512 ' HB3' ' O ' ' A' ' 16' ' ' GLY . 1.2 mt-30 . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.183 -0.948 . . . . 0.0 109.866 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.859 ' HB2' ' HA ' ' A' ' 14' ' ' CYS . 23.6 t . . . . . 0 N--CA 1.489 1.491 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . . . -107.02 -34.24 7.24 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.288 -0.883 . . . . 0.0 109.739 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.449 ' CD2' ' O ' ' A' ' 7' ' ' PHE . 48.5 p90 -104.64 30.78 5.16 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.113 -0.992 . . . . 0.0 109.684 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -103.45 145.38 16.18 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -76.75 -12.54 18.15 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.434 2.089 . . . . 0.0 110.3 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 . . . . . 0 N--CA 1.489 1.481 0 O-C-N 121.126 -0.984 . . . . 0.0 109.058 179.596 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.673 ' N ' ' HG ' ' A' ' 5' ' ' CYS . 13.8 p90 . . . . . 0 N--CA 1.492 1.673 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.59 ' O ' ' HB2' ' A' ' 14' ' ' CYS . 96.8 t -60.7 -56.37 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.168 -0.957 . . . . 0.0 109.593 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.859 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 O-C-N 121.507 -0.746 . . . . 0.0 109.42 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.512 ' O ' ' HB3' ' A' ' 3' ' ' GLN . . . . . . . . 0 N--CA 1.491 2.361 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.5 t30 . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.09 -1.241 . . . . 0.0 109.703 179.813 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.5 p . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.32 0.581 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.498 ' N ' ' HD3' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -104.75 142.77 34.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.288 -0.882 . . . . 0.0 109.061 179.849 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.493 ' HB3' ' O ' ' A' ' 16' ' ' GLY . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.509 0 O-C-N 121.178 -0.951 . . . . 0.0 109.842 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.695 ' HB2' ' HA ' ' A' ' 14' ' ' CYS . 15.9 t . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.27 0.557 . . . . 0.0 109.8 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . . . -120.61 -33.11 3.89 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.327 -0.858 . . . . 0.0 109.313 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -118.48 45.35 2.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.262 -0.899 . . . . 0.0 109.462 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -104.13 158.41 16.8 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.52 -18.45 13.75 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.544 2.163 . . . . 0.0 110.418 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.285 -0.884 . . . . 0.0 109.32 179.727 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 10.9 p90 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.235 0.541 . . . . 0.0 109.563 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.431 ' H ' HG23 ' A' ' 13' ' ' VAL . 2.7 t -53.66 -31.78 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.275 -0.891 . . . . 0.0 109.323 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.695 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 O-C-N 121.355 -0.84 . . . . 0.0 109.634 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.493 ' O ' ' HB3' ' A' ' 3' ' ' GLN . . . . . . . . 0 N--CA 1.49 2.271 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.175 -1.191 . . . . 0.0 109.72 -179.989 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.411 ' C ' ' HG3' ' A' ' 2' ' ' ARG . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.288 0.566 . . . . 0.0 109.495 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.411 ' HG3' ' C ' ' A' ' 1' ' ' CYS . 7.2 mtm180 -142.47 95.02 2.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -0.901 . . . . 0.0 109.259 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.474 ' O ' ' O ' ' A' ' 16' ' ' GLY . 1.4 tt0 . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.063 -1.023 . . . . 0.0 109.244 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.788 ' HB2' ' H ' ' A' ' 14' ' ' CYS . 44.3 t . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 121.362 0.601 . . . . 0.0 109.435 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . . . -108.99 2.19 21.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.299 -0.876 . . . . 0.0 109.615 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.452 ' CD1' ' C ' ' A' ' 7' ' ' PHE . 8.7 p90 -125.61 -14.12 6.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.112 -0.992 . . . . 0.0 109.912 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -67.2 162.37 46.73 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.18 -19.31 12.13 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.582 2.188 . . . . 0.0 110.519 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.214 -0.929 . . . . 0.0 109.613 -179.803 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.59 ' N ' ' HG ' ' A' ' 5' ' ' CYS . 27.4 p90 . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 121.155 0.502 . . . . 0.0 110.196 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.464 ' O ' ' CB ' ' A' ' 14' ' ' CYS . 40.6 t -95.21 -43.79 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.173 -0.954 . . . . 0.0 109.362 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.788 ' H ' ' HB2' ' A' ' 5' ' ' CYS . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.703 0 O-C-N 121.229 -0.92 . . . . 0.0 109.452 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 3' ' ' GLN . . . . . . . . 0 N--CA 1.492 2.405 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 7.5 p30 . . . . . 0 N--CA 1.491 1.608 0 O-C-N 121.248 -1.148 . . . . 0.0 109.291 179.917 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 26.7 p . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -102.52 137.13 41.16 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.162 -0.961 . . . . 0.0 109.717 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.505 0 O-C-N 121.409 -0.807 . . . . 0.0 109.407 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.729 ' HB2' ' CA ' ' A' ' 14' ' ' CYS . 36.3 t . . . . . 0 N--CA 1.494 1.765 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . . . -118.93 -5.35 10.58 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.193 -0.942 . . . . 0.0 109.714 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.406 ' CZ ' ' HA2' ' A' ' 16' ' ' GLY . 14.5 p90 -129.52 19.02 5.75 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.161 -0.962 . . . . 0.0 109.727 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -93.28 162.45 25.88 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.32 -21.03 10.71 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.689 2.259 . . . . 0.0 110.573 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.111 -0.993 . . . . 0.0 109.792 -179.702 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.9 p90 . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.274 0.559 . . . . 0.0 109.628 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.407 ' O ' ' C ' ' A' ' 14' ' ' CYS . 11.5 t -70.88 -23.42 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.26 -0.9 . . . . 0.0 109.333 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.729 ' CA ' ' HB2' ' A' ' 5' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.394 -0.816 . . . . 0.0 110.015 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.406 ' HA2' ' CZ ' ' A' ' 7' ' ' PHE . . . . . . . . 0 N--CA 1.489 2.219 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.35 -1.088 . . . . 0.0 109.305 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 15.8 p . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 121.359 0.6 . . . . 0.0 109.439 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.413 ' HE ' ' HA ' ' A' ' 2' ' ' ARG . 2.7 mmp_? -78.3 141.45 38.48 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.22 -0.925 . . . . 0.0 109.341 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.462 0 O-C-N 121.312 -0.867 . . . . 0.0 109.463 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.863 ' HB3' ' HA ' ' A' ' 14' ' ' CYS . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . . . -119.84 -25.96 5.74 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.156 -0.965 . . . . 0.0 109.579 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -128.72 66.97 1.4 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.195 -0.941 . . . . 0.0 109.718 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -120.66 174.15 15.64 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.2 -19.13 12.24 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.693 2.262 . . . . 0.0 110.396 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.284 -0.885 . . . . 0.0 109.39 -179.958 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 21.5 p90 . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.252 0.548 . . . . 0.0 109.648 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 74.4 t -61.2 -49.66 83.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.167 -0.958 . . . . 0.0 109.257 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.863 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.361 -0.837 . . . . 0.0 109.948 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.186 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 61.4 t30 . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.227 -1.161 . . . . 0.0 109.45 -179.928 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 12.9 mtm180 57.36 -167.27 0.13 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.218 -0.926 . . . . 0.0 109.003 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.456 ' O ' ' SG ' ' A' ' 14' ' ' CYS . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.095 -1.003 . . . . 0.0 109.739 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.532 ' HB2' ' H ' ' A' ' 14' ' ' CYS . 51.1 t . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 121.247 0.546 . . . . 0.0 109.593 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . . . -102.04 -58.01 1.96 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.191 -0.943 . . . . 0.0 109.512 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -119.11 132.68 56.02 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.278 -0.889 . . . . 0.0 109.468 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.97 167.71 22.81 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.426 -1.469 . . . . 0.0 109.426 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.03 -10.1 17.97 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.616 2.211 . . . . 0.0 110.401 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.243 -0.91 . . . . 0.0 109.419 179.821 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 43.9 p90 . . . . . 0 N--CA 1.492 1.668 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.454 ' O ' ' O ' ' A' ' 14' ' ' CYS . 16.6 t -121.64 -13.67 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.154 -0.966 . . . . 0.0 109.676 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.532 ' H ' ' HB2' ' A' ' 5' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 O-C-N 121.198 -0.939 . . . . 0.0 109.078 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.408 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 12.0 t30 . . . . . 0 N--CA 1.488 1.457 0 O-C-N 121.382 -1.069 . . . . 0.0 109.526 -179.936 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.428 ' C ' ' HD3' ' A' ' 2' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.428 ' HD3' ' C ' ' A' ' 1' ' ' CYS . 0.0 OUTLIER -114.3 162.98 15.9 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.294 -0.879 . . . . 0.0 109.188 179.9 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.696 ' O ' ' HB2' ' A' ' 4' ' ' DAL . 2.5 tt0 -117.29 113.34 22.02 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.122 -0.986 . . . . 0.0 109.8 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' DAL . . . . . 0.696 ' HB2' ' O ' ' A' ' 3' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.496 ' N ' ' HA ' ' A' ' 14' ' ' CYS . 0.1 OUTLIER 60.77 103.11 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.206 -0.934 . . . . 0.0 109.4 -179.962 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . . . -99.68 -13.51 19.31 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.331 -0.856 . . . . 0.0 109.099 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.526 ' N ' ' CD1' ' A' ' 7' ' ' PHE . 0.2 OUTLIER -136.91 57.49 1.76 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.411 -0.806 . . . . 0.0 109.136 179.78 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -118.66 -175.37 16.38 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.78 -35.17 1.54 Allowed 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.624 2.216 . . . . 0.0 110.329 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -120.24 -74.97 0.59 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.314 -0.866 . . . . 0.0 109.322 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' DBB . . . . . 0.408 ' HB3' ' O ' ' A' ' 5' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -135.68 0.62 2.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.821 -1.175 . . . . 0.0 110.041 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.804 ' O ' ' HB2' ' A' ' 14' ' ' CYS . 13.4 t -85.12 -50.49 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.041 -1.037 . . . . 0.0 109.563 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.804 ' HB2' ' O ' ' A' ' 13' ' ' VAL . 12.5 m 78.49 79.29 0.06 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.404 -0.81 . . . . 0.0 109.168 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' BH2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.494 ' O ' ' HG3' ' A' ' 3' ' ' GLN . . . 179.79 173.97 45.3 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -135.47 173.18 12.01 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.252 -1.146 . . . . 0.0 109.489 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.361 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LSP . . . . . 0.573 ' H2 ' HG21 ' A' ' 13' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 4.4 t . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 121.173 0.511 . . . . 0.0 109.689 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.04 -162.82 0.08 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.198 -0.939 . . . . 0.0 109.189 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.707 ' O ' ' HB2' ' A' ' 4' ' ' DAL . 0.0 OUTLIER -140.72 122.74 15.59 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.245 -0.909 . . . . 0.0 109.809 179.712 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 4' ' ' DAL . . . . . 0.707 ' HB2' ' O ' ' A' ' 3' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.517 ' N ' ' HA ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER 50.72 91.5 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.106 -0.996 . . . . 0.0 109.347 179.845 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . . . -106.97 8.59 30.55 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.205 -0.935 . . . . 0.0 109.525 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.505 ' O ' ' CG ' ' A' ' 7' ' ' PHE . 4.8 p90 -139.69 39.59 2.02 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.192 -0.942 . . . . 0.0 109.748 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -121.13 170.63 14.64 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.434 ' HD2' ' H12' ' A' ' 100' ' ' LSP . 35.6 Cg_endo -78.56 -30.75 2.96 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.537 2.158 . . . . 0.0 109.964 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -100.14 -80.87 0.47 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.361 -0.837 . . . . 0.0 109.144 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' DBB . . . . . 0.471 ' HB3' ' O ' ' A' ' 5' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -138.23 6.24 2.57 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.938 -1.101 . . . . 0.0 109.91 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.883 HG21 ' H2 ' ' A' ' 100' ' ' LSP . 3.4 t -91.72 -30.39 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.277 -0.889 . . . . 0.0 109.244 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.517 ' HA ' ' N ' ' A' ' 5' ' ' CYS . 1.6 m 56.62 82.85 0.11 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.324 -0.86 . . . . 0.0 109.916 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' BH2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.22 149.85 23.27 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -101.4 73.62 1.49 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.347 -1.09 . . . . 0.0 109.473 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' DBB . . . . . 0.4 ' O ' ' HG3' ' A' ' 19' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.466 ' OXT' ' HA ' ' A' ' 3' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.295 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LSP . . . . . 0.883 ' H2 ' HG21 ' A' ' 13' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.472 ' SG ' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.424 ' NE ' ' HA ' ' A' ' 2' ' ' ARG . 1.5 mmp_? -67.25 108.4 2.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.334 -0.854 . . . . 0.0 109.653 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.698 ' O ' ' HB2' ' A' ' 4' ' ' DAL . 0.0 OUTLIER -107.58 40.05 1.79 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.334 -0.854 . . . . 0.0 109.403 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 4' ' ' DAL . . . . . 0.698 ' HB2' ' O ' ' A' ' 3' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.851 ' HB3' ' HA ' ' A' ' 14' ' ' CYS . 0.7 OUTLIER 67.66 99.83 0.05 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.355 -0.841 . . . . 0.0 109.527 -179.842 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . . . -113.64 -6.91 13.35 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.282 -0.887 . . . . 0.0 109.424 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.518 ' CZ ' ' HA3' ' A' ' 16' ' ' GLY . 0.2 OUTLIER -132.41 43.07 3.04 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.291 -0.881 . . . . 0.0 109.453 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -127.5 147.33 17.04 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -77.38 -3.62 13.85 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.545 2.163 . . . . 0.0 110.58 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.58 ' HB3' ' CD2' ' A' ' 12' ' ' PHE . 26.3 m-85 -101.46 -80.56 0.5 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.198 -0.939 . . . . 0.0 109.292 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.58 ' CD2' ' HB3' ' A' ' 10' ' ' PHE . 34.0 p90 -120.84 -4.16 9.67 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.27 -0.894 . . . . 0.0 109.23 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.686 ' O ' ' HB2' ' A' ' 14' ' ' CYS . 96.8 t -81.94 -55.54 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.235 -0.916 . . . . 0.0 109.294 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.851 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 1.3 m 73.24 74.16 0.13 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.277 -0.889 . . . . 0.0 109.509 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' BH2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.518 ' HA3' ' CZ ' ' A' ' 7' ' ' PHE . . . -109.0 117.22 4.87 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -138.16 117.89 13.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.219 -1.165 . . . . 0.0 109.595 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.472 ' N ' ' SG ' ' A' ' 1' ' ' CYS . 33.9 mtpt . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.417 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LSP . . . . . 0.798 ' HN3' ' HB2' ' A' ' 5' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 7.1 t . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.245 0.545 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.418 ' C ' ' OXT' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -116.24 161.99 18.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.319 -0.863 . . . . 0.0 109.31 179.896 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.68 ' O ' ' HB2' ' A' ' 4' ' ' DAL . 6.7 pt20 -134.96 101.01 4.75 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.228 -0.92 . . . . 0.0 109.593 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' DAL . . . . . 0.68 ' HB2' ' O ' ' A' ' 3' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.426 ' HB2' ' HG3' ' A' ' 11' ' ' DBB . 0.0 OUTLIER -75.42 106.98 7.24 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.258 -0.901 . . . . 0.0 109.237 179.894 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . . . -99.94 -45.5 5.67 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.201 -0.937 . . . . 0.0 109.672 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.549 ' O ' ' CG ' ' A' ' 7' ' ' PHE . 35.5 p90 -135.33 116.78 14.71 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.226 -0.921 . . . . 0.0 109.447 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -169.82 173.26 43.97 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.0 -34.7 1.61 Allowed 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.599 2.199 . . . . 0.0 110.315 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -100.0 -83.64 0.43 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.196 -0.94 . . . . 0.0 109.255 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' DBB . . . . . 0.426 ' HG3' ' HB2' ' A' ' 5' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.485 ' CE1' HG23 ' A' ' 13' ' ' VAL . 2.1 p90 -140.52 12.45 2.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.956 -1.09 . . . . 0.0 109.189 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.841 HG21 ' H2 ' ' A' ' 100' ' ' LSP . 80.8 t -114.42 107.72 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.285 -0.884 . . . . 0.0 109.33 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.468 ' SG ' ' O ' ' A' ' 3' ' ' GLN . 0.0 OUTLIER -58.58 151.48 20.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.426 -0.797 . . . . 0.0 109.523 -179.796 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' BH2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.41 ' O ' ' CB ' ' A' ' 3' ' ' GLN . . . 150.47 -131.67 3.66 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -110.34 143.23 40.87 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.274 -1.133 . . . . 0.0 109.575 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.491 ' CB ' ' NZ ' ' A' ' 19' ' ' LYS . 7.4 mtpm? . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 117.987 -1.006 . . . . 0.0 109.486 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LSP . . . . . 0.841 ' H2 ' HG21 ' A' ' 13' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.465 ' O ' ' HG2' ' A' ' 3' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.418 ' CD ' ' H ' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -66.69 120.22 13.12 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.206 -0.934 . . . . 0.0 108.843 179.64 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.702 ' O ' ' HB2' ' A' ' 4' ' ' DAL . 1.2 mt-30 -125.66 91.56 3.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.183 -0.948 . . . . 0.0 109.866 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' DAL . . . . . 0.702 ' HB2' ' O ' ' A' ' 3' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.859 ' HB2' ' HA ' ' A' ' 14' ' ' CYS . 23.6 t 75.03 84.48 0.1 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.252 -0.905 . . . . 0.0 109.111 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . . . -107.02 -34.24 7.24 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.288 -0.883 . . . . 0.0 109.739 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.548 ' CE2' H111 ' A' ' 100' ' ' LSP . 48.5 p90 -104.64 30.78 5.16 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.113 -0.992 . . . . 0.0 109.684 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -103.45 145.38 16.18 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -76.75 -12.54 18.15 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.434 2.089 . . . . 0.0 110.3 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -109.0 -72.65 0.72 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.126 -0.984 . . . . 0.0 109.058 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.432 ' CD1' ' C ' ' A' ' 12' ' ' PHE . 13.8 p90 -127.42 -29.65 2.68 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.124 -0.985 . . . . 0.0 109.627 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.59 ' O ' ' HB2' ' A' ' 14' ' ' CYS . 96.8 t -60.7 -56.37 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.168 -0.957 . . . . 0.0 109.593 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.859 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 0.0 OUTLIER 77.73 79.36 0.07 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.507 -0.746 . . . . 0.0 109.42 -179.793 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' BH2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.512 ' O ' ' HB3' ' A' ' 3' ' ' GLN . . . -82.01 143.27 23.0 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -141.4 68.17 1.34 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.09 -1.241 . . . . 0.0 109.703 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.033 -1.042 . . . . 0.0 109.394 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LSP . . . . . 0.548 H111 ' CE2' ' A' ' 7' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.5 p . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.32 0.581 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.498 ' HD3' ' N ' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -104.75 142.77 34.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.288 -0.882 . . . . 0.0 109.061 179.849 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.721 ' O ' ' HB2' ' A' ' 4' ' ' DAL . 0.8 OUTLIER -140.23 114.74 9.35 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.178 -0.951 . . . . 0.0 109.842 -179.827 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' DAL . . . . . 0.864 ' O ' ' HB3' ' A' ' 5' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.864 ' HB3' ' O ' ' A' ' 4' ' ' DAL . 15.9 t 75.08 111.82 0.07 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.194 -0.941 . . . . 0.0 109.8 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . . . -120.61 -33.11 3.89 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.327 -0.858 . . . . 0.0 109.313 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.488 ' CD1' H111 ' A' ' 100' ' ' LSP . 2.2 p90 -118.48 45.35 2.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.262 -0.899 . . . . 0.0 109.462 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.416 ' HA2' H112 ' A' ' 100' ' ' LSP . . . -104.13 158.41 16.8 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.52 -18.45 13.75 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.544 2.163 . . . . 0.0 110.418 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -113.16 -67.25 1.01 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.285 -0.884 . . . . 0.0 109.32 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -113.54 -25.58 8.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.034 -1.041 . . . . 0.0 109.563 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.596 HG21 ' H2 ' ' A' ' 100' ' ' LSP . 2.7 t -53.66 -31.78 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.275 -0.891 . . . . 0.0 109.323 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.695 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 0.9 OUTLIER 53.38 71.72 0.48 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.355 -0.84 . . . . 0.0 109.634 179.785 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' BH2 . . . . . 0.452 ' HB ' H122 ' A' ' 100' ' ' LSP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.493 ' O ' ' HB3' ' A' ' 3' ' ' GLN . . . -176.74 -170.5 39.34 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -140.19 141.21 35.99 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.175 -1.191 . . . . 0.0 109.72 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 3' ' ' GLN . 6.2 mtmt . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 118.028 -0.986 . . . . 0.0 109.532 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LSP . . . . . 0.596 ' H2 ' HG21 ' A' ' 13' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.411 ' C ' ' HG3' ' A' ' 2' ' ' ARG . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.288 0.566 . . . . 0.0 109.495 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.451 ' O ' ' HG3' ' A' ' 19' ' ' LYS . 7.2 mtm180 -142.47 95.02 2.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -0.901 . . . . 0.0 109.259 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.75 ' HB2' ' H ' ' A' ' 18' ' ' DBB . 1.4 tt0 -99.52 62.04 1.2 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.063 -1.023 . . . . 0.0 109.244 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' DAL . . . . . 0.811 ' O ' ' HB3' ' A' ' 5' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.811 ' HB3' ' O ' ' A' ' 4' ' ' DAL . 44.3 t 79.33 73.24 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.536 -0.727 . . . . 0.0 109.435 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . . . -108.99 2.19 21.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.299 -0.876 . . . . 0.0 109.615 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.452 ' CD1' ' C ' ' A' ' 7' ' ' PHE . 8.7 p90 -125.61 -14.12 6.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.112 -0.992 . . . . 0.0 109.912 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -67.2 162.37 46.73 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.18 -19.31 12.13 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.582 2.188 . . . . 0.0 110.519 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -106.64 -86.64 0.48 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.214 -0.929 . . . . 0.0 109.613 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -128.34 8.07 5.96 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.62 -1.3 . . . . 0.0 110.196 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.914 HG21 ' H12' ' A' ' 100' ' ' LSP . 40.6 t -95.21 -43.79 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.173 -0.954 . . . . 0.0 109.362 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.788 ' H ' ' HB2' ' A' ' 5' ' ' CYS . 0.5 OUTLIER 72.77 125.91 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.229 -0.92 . . . . 0.0 109.452 179.891 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' BH2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 3' ' ' GLN . . . 169.93 -137.05 4.28 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -139.1 143.26 38.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.248 -1.148 . . . . 0.0 109.291 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' DBB . . . . . 0.75 ' H ' ' HB2' ' A' ' 3' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.487 ' HG3' ' HA ' ' A' ' 3' ' ' GLN . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.078 -1.014 . . . . 0.0 109.446 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LSP . . . . . 0.914 ' H12' HG21 ' A' ' 13' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 26.7 p . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.523 ' HB2' ' CD ' ' A' ' 19' ' ' LYS . 2.6 mmp_? -102.52 137.13 41.16 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.162 -0.961 . . . . 0.0 109.717 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.691 ' O ' ' HB2' ' A' ' 4' ' ' DAL . 0.0 OUTLIER -119.83 60.09 0.86 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.409 -0.807 . . . . 0.0 109.407 -179.972 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 4' ' ' DAL . . . . . 0.775 ' O ' ' HB3' ' A' ' 5' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.775 ' HB3' ' O ' ' A' ' 4' ' ' DAL . 36.3 t 73.88 91.74 0.08 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.336 -0.853 . . . . 0.0 109.546 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . . . -118.93 -5.35 10.58 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.193 -0.942 . . . . 0.0 109.714 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.406 ' CZ ' ' HA2' ' A' ' 16' ' ' GLY . 14.5 p90 -129.52 19.02 5.75 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.161 -0.962 . . . . 0.0 109.727 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.403 ' H ' ' HG1' ' A' ' 11' ' ' DBB . . . -93.28 162.45 25.88 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.32 -21.03 10.71 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.689 2.259 . . . . 0.0 110.573 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -105.48 -54.58 2.46 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.111 -0.993 . . . . 0.0 109.792 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' DBB . . . . . 0.403 ' HG1' ' H ' ' A' ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -100.9 -10.33 20.75 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.185 -0.947 . . . . 0.0 109.628 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.592 HG21 ' H2 ' ' A' ' 100' ' ' LSP . 11.5 t -70.88 -23.42 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.26 -0.9 . . . . 0.0 109.333 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.729 ' CA ' ' HB2' ' A' ' 5' ' ' CYS . 0.0 OUTLIER 43.66 65.04 1.08 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.394 -0.816 . . . . 0.0 110.015 -179.911 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' BH2 . . . . . 0.46 ' O ' ' OB ' ' A' ' 15' ' ' BH2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.406 ' HA2' ' CZ ' ' A' ' 7' ' ' PHE . . . -154.89 124.07 1.46 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.473 ' O ' ' HG3' ' A' ' 18' ' ' DBB . 0.1 OUTLIER -121.36 34.84 5.06 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.35 -1.088 . . . . 0.0 109.305 179.715 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' DBB . . . . . 0.473 ' HG3' ' O ' ' A' ' 17' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.523 ' CD ' ' HB2' ' A' ' 2' ' ' ARG . 7.8 mtpp . . . . . 0 N--CA 1.49 1.554 0 O-C-N 120.967 -1.083 . . . . 0.0 109.536 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LSP . . . . . 0.592 ' H2 ' HG21 ' A' ' 13' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 15.8 p . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 121.359 0.6 . . . . 0.0 109.439 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.429 ' O ' ' C ' ' A' ' 19' ' ' LYS . 2.7 mmp_? -78.3 141.45 38.48 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.22 -0.925 . . . . 0.0 109.341 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.684 ' O ' ' HB2' ' A' ' 4' ' ' DAL . 0.4 OUTLIER -138.84 103.64 4.87 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.312 -0.867 . . . . 0.0 109.463 -179.769 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 4' ' ' DAL . . . . . 0.684 ' HB2' ' O ' ' A' ' 3' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.863 ' HB3' ' HA ' ' A' ' 14' ' ' CYS . 0.5 OUTLIER 75.65 111.1 0.07 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.153 -0.967 . . . . 0.0 109.184 -179.646 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.406 ' CB ' ' HB2' ' A' ' 19' ' ' LYS . . . -119.84 -25.96 5.74 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.156 -0.965 . . . . 0.0 109.579 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -128.72 66.97 1.4 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.195 -0.941 . . . . 0.0 109.718 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -120.66 174.15 15.64 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.2 -19.13 12.24 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.693 2.262 . . . . 0.0 110.396 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -134.8 -55.58 0.83 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.284 -0.885 . . . . 0.0 109.39 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -116.34 -21.06 9.47 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.145 -0.972 . . . . 0.0 109.648 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.535 HG21 ' H2 ' ' A' ' 100' ' ' LSP . 74.4 t -61.2 -49.66 83.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.167 -0.958 . . . . 0.0 109.257 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.863 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 0.0 OUTLIER 69.49 45.9 0.78 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.361 -0.837 . . . . 0.0 109.948 179.685 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' BH2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -106.87 159.47 14.72 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -133.38 126.9 32.29 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.227 -1.161 . . . . 0.0 109.45 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 2' ' ' ARG . 6.1 mtmp? . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 117.947 -1.025 . . . . 0.0 109.552 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LSP . . . . . 0.535 ' H2 ' HG21 ' A' ' 13' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.449 ' O ' ' OXT' ' A' ' 19' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 12.9 mtm180 57.36 -167.27 0.13 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.218 -0.926 . . . . 0.0 109.003 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.678 ' O ' ' HB2' ' A' ' 4' ' ' DAL . 0.8 OUTLIER -139.55 111.42 7.34 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.095 -1.003 . . . . 0.0 109.739 -179.755 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' DAL . . . . . 0.678 ' HB2' ' O ' ' A' ' 3' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.59 ' HB3' ' O ' ' A' ' 11' ' ' DBB . 51.1 t -68.16 108.9 3.32 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.224 -0.922 . . . . 0.0 109.593 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . . . -102.04 -58.01 1.96 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.191 -0.943 . . . . 0.0 109.512 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -119.11 132.68 56.02 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.278 -0.889 . . . . 0.0 109.468 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.97 167.71 22.81 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.426 -1.469 . . . . 0.0 109.426 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.03 -10.1 17.97 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.616 2.211 . . . . 0.0 110.401 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -106.05 -90.43 0.42 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.243 -0.91 . . . . 0.0 109.419 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' DBB . . . . . 0.59 ' O ' ' HB3' ' A' ' 5' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -139.94 37.45 1.96 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.125 -0.985 . . . . 0.0 109.523 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.801 HG11 ' O21' ' A' ' 100' ' ' LSP . 16.6 t -121.64 -13.67 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.154 -0.966 . . . . 0.0 109.676 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.532 ' H ' ' HB2' ' A' ' 5' ' ' CYS . 0.0 OUTLIER 60.77 147.73 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.198 -0.939 . . . . 0.0 109.078 -179.755 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' BH2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 170.89 -155.05 23.99 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.407 ' ND2' ' HG3' ' A' ' 18' ' ' DBB . 12.0 t30 -102.09 149.95 23.74 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.382 -1.069 . . . . 0.0 109.526 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' DBB . . . . . 0.407 ' HG3' ' ND2' ' A' ' 17' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.449 ' OXT' ' O ' ' A' ' 1' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 117.908 -1.044 . . . . 0.0 109.587 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LSP . . . . . 0.801 ' O21' HG11 ' A' ' 13' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.428 ' C ' ' HD3' ' A' ' 2' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.428 ' HD3' ' C ' ' A' ' 1' ' ' CYS . 0.0 OUTLIER -114.3 162.98 15.9 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.294 -0.879 . . . . 0.0 109.188 179.9 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.494 ' HG3' ' O ' ' A' ' 16' ' ' GLY . 2.5 tt0 . . . . . 0 N--CA 1.489 1.501 0 O-C-N 121.122 -0.986 . . . . 0.0 109.8 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.77 ' HG ' ' N ' ' A' ' 12' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . . . -99.68 -13.51 19.31 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.331 -0.856 . . . . 0.0 109.099 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.526 ' N ' ' CD1' ' A' ' 7' ' ' PHE . 0.2 OUTLIER -136.91 57.49 1.76 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.411 -0.806 . . . . 0.0 109.136 179.78 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -118.66 -175.37 16.38 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.78 -35.17 1.54 Allowed 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.624 2.216 . . . . 0.0 110.329 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 . . . . . 0 N--CA 1.489 1.502 0 O-C-N 121.314 -0.866 . . . . 0.0 109.322 179.888 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.77 ' N ' ' HG ' ' A' ' 5' ' ' CYS . 31.0 p90 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.075 0.464 . . . . 0.0 110.041 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.804 ' O ' ' HB2' ' A' ' 14' ' ' CYS . 13.4 t -85.12 -50.49 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.041 -1.037 . . . . 0.0 109.563 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.804 ' HB2' ' O ' ' A' ' 13' ' ' VAL . 12.5 m . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.404 -0.81 . . . . 0.0 109.168 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.494 ' O ' ' HG3' ' A' ' 3' ' ' GLN . . . . . . . . 0 N--CA 1.49 2.268 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.252 -1.146 . . . . 0.0 109.489 -179.986 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 4.4 t . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 121.173 0.511 . . . . 0.0 109.689 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.04 -162.82 0.08 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.198 -0.939 . . . . 0.0 109.189 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.431 ' O ' ' SG ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.404 0 O-C-N 121.245 -0.909 . . . . 0.0 109.809 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.718 ' HG ' ' N ' ' A' ' 12' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . . . -106.97 8.59 30.55 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.205 -0.935 . . . . 0.0 109.525 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.505 ' O ' ' CG ' ' A' ' 7' ' ' PHE . 4.8 p90 -139.69 39.59 2.02 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.192 -0.942 . . . . 0.0 109.748 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -121.13 170.63 14.64 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.56 -30.75 2.96 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.537 2.158 . . . . 0.0 109.964 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.492 0 O-C-N 121.361 -0.837 . . . . 0.0 109.144 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.718 ' N ' ' HG ' ' A' ' 5' ' ' CYS . 8.4 p90 . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.085 0.469 . . . . 0.0 109.91 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.4 t -91.72 -30.39 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.277 -0.889 . . . . 0.0 109.244 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.517 ' HA ' ' N ' ' A' ' 5' ' ' CYS . 1.6 m . . . . . 0 N--CA 1.492 1.648 0 O-C-N 121.324 -0.86 . . . . 0.0 109.916 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.301 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 4.8 t30 . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.347 -1.09 . . . . 0.0 109.473 179.919 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.424 ' NE ' ' HA ' ' A' ' 2' ' ' ARG . 1.5 mmp_? -67.25 108.4 2.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.334 -0.854 . . . . 0.0 109.653 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.442 ' HA ' ' O ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.304 -1.407 0 O-C-N 121.334 -0.854 . . . . 0.0 109.403 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.851 ' HB3' ' HA ' ' A' ' 14' ' ' CYS . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.258 0.551 . . . . 0.0 109.527 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . . . -113.64 -6.91 13.35 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.282 -0.887 . . . . 0.0 109.424 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.518 ' CZ ' ' HA3' ' A' ' 16' ' ' GLY . 0.2 OUTLIER -132.41 43.07 3.04 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.291 -0.881 . . . . 0.0 109.453 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -127.5 147.33 17.04 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -77.38 -3.62 13.85 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.545 2.163 . . . . 0.0 110.58 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.58 ' HB3' ' CD2' ' A' ' 12' ' ' PHE . 26.3 m-85 . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.198 -0.939 . . . . 0.0 109.292 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.58 ' CD2' ' HB3' ' A' ' 10' ' ' PHE . 34.0 p90 . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.686 ' O ' ' HB2' ' A' ' 14' ' ' CYS . 96.8 t -81.94 -55.54 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.235 -0.916 . . . . 0.0 109.294 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.851 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 1.3 m . . . . . 0 N--CA 1.489 1.503 0 O-C-N 121.277 -0.889 . . . . 0.0 109.509 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.518 ' HA3' ' CZ ' ' A' ' 7' ' ' PHE . . . . . . . . 0 N--CA 1.49 2.255 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.219 -1.165 . . . . 0.0 109.595 -179.889 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 7.1 t . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.245 0.545 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.24 161.99 18.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.319 -0.863 . . . . 0.0 109.31 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.468 ' HG3' ' O ' ' A' ' 3' ' ' GLN . 6.7 pt20 . . . . . 0 N--CA 1.489 1.505 0 O-C-N 121.228 -0.92 . . . . 0.0 109.593 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.407 ' SG ' ' O ' ' A' ' 5' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . . . -99.94 -45.5 5.67 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.201 -0.937 . . . . 0.0 109.672 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.549 ' O ' ' CG ' ' A' ' 7' ' ' PHE . 35.5 p90 -135.33 116.78 14.71 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.226 -0.921 . . . . 0.0 109.447 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -169.82 173.26 43.97 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.0 -34.7 1.61 Allowed 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.599 2.199 . . . . 0.0 110.315 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.196 -0.94 . . . . 0.0 109.255 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.485 ' CE1' HG23 ' A' ' 13' ' ' VAL . 2.1 p90 . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.485 HG23 ' CE1' ' A' ' 12' ' ' PHE . 80.8 t -114.42 107.72 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.285 -0.884 . . . . 0.0 109.33 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.468 ' SG ' ' O ' ' A' ' 3' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.531 0 O-C-N 121.426 -0.797 . . . . 0.0 109.523 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.41 ' O ' ' CB ' ' A' ' 3' ' ' GLN . . . . . . . . 0 N--CA 1.49 2.297 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.274 -1.133 . . . . 0.0 109.575 -179.888 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.465 ' O ' ' HG2' ' A' ' 3' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.418 ' CD ' ' H ' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -66.69 120.22 13.12 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.206 -0.934 . . . . 0.0 108.843 179.64 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.512 ' HB3' ' O ' ' A' ' 16' ' ' GLY . 1.2 mt-30 . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.183 -0.948 . . . . 0.0 109.866 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.859 ' HB2' ' HA ' ' A' ' 14' ' ' CYS . 23.6 t . . . . . 0 N--CA 1.489 1.491 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . . . -107.02 -34.24 7.24 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.288 -0.883 . . . . 0.0 109.739 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.449 ' O ' ' CD2' ' A' ' 7' ' ' PHE . 48.5 p90 -104.64 30.78 5.16 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.113 -0.992 . . . . 0.0 109.684 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -103.45 145.38 16.18 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -76.75 -12.54 18.15 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.434 2.089 . . . . 0.0 110.3 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 . . . . . 0 N--CA 1.489 1.481 0 O-C-N 121.126 -0.984 . . . . 0.0 109.058 179.596 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.673 ' N ' ' HG ' ' A' ' 5' ' ' CYS . 13.8 p90 . . . . . 0 N--CA 1.492 1.673 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.59 ' O ' ' HB2' ' A' ' 14' ' ' CYS . 96.8 t -60.7 -56.37 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.168 -0.957 . . . . 0.0 109.593 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.859 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 O-C-N 121.507 -0.746 . . . . 0.0 109.42 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.512 ' O ' ' HB3' ' A' ' 3' ' ' GLN . . . . . . . . 0 N--CA 1.491 2.361 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.5 t30 . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.09 -1.241 . . . . 0.0 109.703 179.813 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.439 ' SG ' ' ND2' ' A' ' 17' ' ' ASN . 1.5 p . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.32 0.581 . . . . 0.0 109.502 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.498 ' HD3' ' N ' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -104.75 142.77 34.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.288 -0.882 . . . . 0.0 109.061 179.849 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.493 ' HB3' ' O ' ' A' ' 16' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.509 0 O-C-N 121.178 -0.951 . . . . 0.0 109.842 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.695 ' HB2' ' HA ' ' A' ' 14' ' ' CYS . 15.9 t . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.27 0.557 . . . . 0.0 109.8 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . . . -120.61 -33.11 3.89 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.327 -0.858 . . . . 0.0 109.313 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -118.48 45.35 2.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.262 -0.899 . . . . 0.0 109.462 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -104.13 158.41 16.8 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.52 -18.45 13.75 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.544 2.163 . . . . 0.0 110.418 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.285 -0.884 . . . . 0.0 109.32 179.727 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 10.9 p90 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.235 0.541 . . . . 0.0 109.563 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.431 ' H ' HG23 ' A' ' 13' ' ' VAL . 2.7 t -53.66 -31.78 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.275 -0.891 . . . . 0.0 109.323 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.695 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 O-C-N 121.355 -0.84 . . . . 0.0 109.634 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.493 ' O ' ' HB3' ' A' ' 3' ' ' GLN . . . . . . . . 0 N--CA 1.49 2.271 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.439 ' ND2' ' SG ' ' A' ' 1' ' ' CYS . 26.5 t30 . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.175 -1.191 . . . . 0.0 109.72 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.411 ' C ' ' HG3' ' A' ' 2' ' ' ARG . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.288 0.566 . . . . 0.0 109.495 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.411 ' HG3' ' C ' ' A' ' 1' ' ' CYS . 7.2 mtm180 -142.47 95.02 2.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -0.901 . . . . 0.0 109.259 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.474 ' O ' ' O ' ' A' ' 16' ' ' GLY . 1.4 tt0 . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.063 -1.023 . . . . 0.0 109.244 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.788 ' HB2' ' H ' ' A' ' 14' ' ' CYS . 44.3 t . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 121.362 0.601 . . . . 0.0 109.435 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . . . -108.99 2.19 21.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.299 -0.876 . . . . 0.0 109.615 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.452 ' CD1' ' C ' ' A' ' 7' ' ' PHE . 8.7 p90 -125.61 -14.12 6.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.112 -0.992 . . . . 0.0 109.912 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -67.2 162.37 46.73 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.18 -19.31 12.13 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.582 2.188 . . . . 0.0 110.519 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.214 -0.929 . . . . 0.0 109.613 -179.803 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.59 ' N ' ' HG ' ' A' ' 5' ' ' CYS . 27.4 p90 . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 121.155 0.502 . . . . 0.0 110.196 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.464 ' O ' ' CB ' ' A' ' 14' ' ' CYS . 40.6 t -95.21 -43.79 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.173 -0.954 . . . . 0.0 109.362 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.788 ' H ' ' HB2' ' A' ' 5' ' ' CYS . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.703 0 O-C-N 121.229 -0.92 . . . . 0.0 109.452 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 3' ' ' GLN . . . . . . . . 0 N--CA 1.492 2.405 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 O-C-N 121.248 -1.148 . . . . 0.0 109.291 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 26.7 p . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.6 mmp_? -102.52 137.13 41.16 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.162 -0.961 . . . . 0.0 109.717 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.505 0 O-C-N 121.409 -0.807 . . . . 0.0 109.407 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.729 ' HB2' ' CA ' ' A' ' 14' ' ' CYS . 36.3 t . . . . . 0 N--CA 1.494 1.765 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . . . -118.93 -5.35 10.58 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.193 -0.942 . . . . 0.0 109.714 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.406 ' CZ ' ' HA2' ' A' ' 16' ' ' GLY . 14.5 p90 -129.52 19.02 5.75 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.161 -0.962 . . . . 0.0 109.727 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -93.28 162.45 25.88 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.32 -21.03 10.71 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.689 2.259 . . . . 0.0 110.573 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.111 -0.993 . . . . 0.0 109.792 -179.702 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.9 p90 . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.274 0.559 . . . . 0.0 109.628 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.407 ' O ' ' C ' ' A' ' 14' ' ' CYS . 11.5 t -70.88 -23.42 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.26 -0.9 . . . . 0.0 109.333 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.729 ' CA ' ' HB2' ' A' ' 5' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.394 -0.816 . . . . 0.0 110.015 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.406 ' HA2' ' CZ ' ' A' ' 7' ' ' PHE . . . . . . . . 0 N--CA 1.489 2.219 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.35 -1.088 . . . . 0.0 109.305 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 15.8 p . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 121.359 0.6 . . . . 0.0 109.439 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.413 ' HA ' ' HE ' ' A' ' 2' ' ' ARG . 2.7 mmp_? -78.3 141.45 38.48 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.22 -0.925 . . . . 0.0 109.341 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.462 0 O-C-N 121.312 -0.867 . . . . 0.0 109.463 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.863 ' HB3' ' HA ' ' A' ' 14' ' ' CYS . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . . . -119.84 -25.96 5.74 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.156 -0.965 . . . . 0.0 109.579 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -128.72 66.97 1.4 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.195 -0.941 . . . . 0.0 109.718 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -120.66 174.15 15.64 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.2 -19.13 12.24 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.693 2.262 . . . . 0.0 110.396 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.284 -0.885 . . . . 0.0 109.39 -179.958 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 21.5 p90 . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.252 0.548 . . . . 0.0 109.648 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 74.4 t -61.2 -49.66 83.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.167 -0.958 . . . . 0.0 109.257 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.863 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.361 -0.837 . . . . 0.0 109.948 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.186 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 61.4 t30 . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.227 -1.161 . . . . 0.0 109.45 -179.928 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 12.9 mtm180 57.36 -167.27 0.13 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.218 -0.926 . . . . 0.0 109.003 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.456 ' O ' ' SG ' ' A' ' 14' ' ' CYS . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.095 -1.003 . . . . 0.0 109.739 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.532 ' HB2' ' H ' ' A' ' 14' ' ' CYS . 51.1 t . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 121.247 0.546 . . . . 0.0 109.593 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . . . -102.04 -58.01 1.96 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.191 -0.943 . . . . 0.0 109.512 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -119.11 132.68 56.02 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.278 -0.889 . . . . 0.0 109.468 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.97 167.71 22.81 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.426 -1.469 . . . . 0.0 109.426 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.03 -10.1 17.97 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.616 2.211 . . . . 0.0 110.401 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.243 -0.91 . . . . 0.0 109.419 179.821 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 43.9 p90 . . . . . 0 N--CA 1.492 1.668 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.454 ' O ' ' O ' ' A' ' 14' ' ' CYS . 16.6 t -121.64 -13.67 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.154 -0.966 . . . . 0.0 109.676 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.532 ' H ' ' HB2' ' A' ' 5' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 O-C-N 121.198 -0.939 . . . . 0.0 109.078 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.408 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 12.0 t30 . . . . . 0 N--CA 1.488 1.457 0 O-C-N 121.382 -1.069 . . . . 0.0 109.526 -179.936 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.428 ' C ' ' HD3' ' A' ' 2' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.428 ' HD3' ' C ' ' A' ' 1' ' ' CYS . 0.0 OUTLIER -114.3 162.98 15.9 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.294 -0.879 . . . . 0.0 109.188 179.9 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.696 ' O ' ' HB2' ' A' ' 4' ' ' DAL . 2.5 tt0 -117.29 113.34 22.02 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.122 -0.986 . . . . 0.0 109.8 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' DAL . . . . . 0.696 ' HB2' ' O ' ' A' ' 3' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.496 ' N ' ' HA ' ' A' ' 14' ' ' CYS . 0.1 OUTLIER 60.77 103.11 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.206 -0.934 . . . . 0.0 109.4 -179.962 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . . . -99.68 -13.51 19.31 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.331 -0.856 . . . . 0.0 109.099 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.526 ' N ' ' CD1' ' A' ' 7' ' ' PHE . 0.2 OUTLIER -136.91 57.49 1.76 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.411 -0.806 . . . . 0.0 109.136 179.78 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -118.66 -175.37 16.38 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.78 -35.17 1.54 Allowed 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.624 2.216 . . . . 0.0 110.329 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -120.24 -74.97 0.59 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.314 -0.866 . . . . 0.0 109.322 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' DBB . . . . . 0.408 ' HB3' ' O ' ' A' ' 5' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -135.68 0.62 2.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.821 -1.175 . . . . 0.0 110.041 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.804 ' O ' ' HB2' ' A' ' 14' ' ' CYS . 13.4 t -85.12 -50.49 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.041 -1.037 . . . . 0.0 109.563 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.804 ' HB2' ' O ' ' A' ' 13' ' ' VAL . 12.5 m 78.49 79.29 0.06 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.404 -0.81 . . . . 0.0 109.168 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' BH2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.494 ' O ' ' HG3' ' A' ' 3' ' ' GLN . . . 179.79 173.97 45.3 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -135.47 173.18 12.01 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.252 -1.146 . . . . 0.0 109.489 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.361 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LSP . . . . . 0.573 ' H2 ' HG21 ' A' ' 13' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 4.4 t . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 121.173 0.511 . . . . 0.0 109.689 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.04 -162.82 0.08 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.198 -0.939 . . . . 0.0 109.189 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.707 ' O ' ' HB2' ' A' ' 4' ' ' DAL . 0.0 OUTLIER -140.72 122.74 15.59 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.245 -0.909 . . . . 0.0 109.809 179.712 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' DAL . . . . . 0.707 ' HB2' ' O ' ' A' ' 3' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.517 ' N ' ' HA ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER 50.72 91.5 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.106 -0.996 . . . . 0.0 109.347 179.845 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . . . -106.97 8.59 30.55 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.205 -0.935 . . . . 0.0 109.525 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.505 ' O ' ' CG ' ' A' ' 7' ' ' PHE . 4.8 p90 -139.69 39.59 2.02 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.192 -0.942 . . . . 0.0 109.748 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -121.13 170.63 14.64 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.434 ' HD2' ' H12' ' A' ' 100' ' ' LSP . 35.6 Cg_endo -78.56 -30.75 2.96 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.537 2.158 . . . . 0.0 109.964 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -100.14 -80.87 0.47 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.361 -0.837 . . . . 0.0 109.144 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' DBB . . . . . 0.471 ' HB3' ' O ' ' A' ' 5' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 8.4 p90 -138.23 6.24 2.57 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.938 -1.101 . . . . 0.0 109.91 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.883 HG21 ' H2 ' ' A' ' 100' ' ' LSP . 3.4 t -91.72 -30.39 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.277 -0.889 . . . . 0.0 109.244 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.517 ' HA ' ' N ' ' A' ' 5' ' ' CYS . 1.6 m 56.62 82.85 0.11 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.324 -0.86 . . . . 0.0 109.916 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' BH2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.22 149.85 23.27 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -101.4 73.62 1.49 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.347 -1.09 . . . . 0.0 109.473 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' DBB . . . . . 0.4 ' O ' ' HG3' ' A' ' 19' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.466 ' OXT' ' HA ' ' A' ' 3' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.295 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LSP . . . . . 0.883 ' H2 ' HG21 ' A' ' 13' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.472 ' SG ' ' N ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.424 ' NE ' ' HA ' ' A' ' 2' ' ' ARG . 1.5 mmp_? -67.25 108.4 2.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.334 -0.854 . . . . 0.0 109.653 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.698 ' O ' ' HB2' ' A' ' 4' ' ' DAL . 0.0 OUTLIER -107.58 40.05 1.79 Allowed 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.334 -0.854 . . . . 0.0 109.403 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' DAL . . . . . 0.698 ' HB2' ' O ' ' A' ' 3' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.851 ' HB3' ' HA ' ' A' ' 14' ' ' CYS . 0.7 OUTLIER 67.66 99.83 0.05 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.355 -0.841 . . . . 0.0 109.527 -179.842 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . . . -113.64 -6.91 13.35 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.282 -0.887 . . . . 0.0 109.424 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.518 ' CZ ' ' HA3' ' A' ' 16' ' ' GLY . 0.2 OUTLIER -132.41 43.07 3.04 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.291 -0.881 . . . . 0.0 109.453 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -127.5 147.33 17.04 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -77.38 -3.62 13.85 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.545 2.163 . . . . 0.0 110.58 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.58 ' HB3' ' CD2' ' A' ' 12' ' ' PHE . 26.3 m-85 -101.46 -80.56 0.5 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.198 -0.939 . . . . 0.0 109.292 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.58 ' CD2' ' HB3' ' A' ' 10' ' ' PHE . 34.0 p90 -120.84 -4.16 9.67 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.27 -0.894 . . . . 0.0 109.23 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.686 ' O ' ' HB2' ' A' ' 14' ' ' CYS . 96.8 t -81.94 -55.54 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.235 -0.916 . . . . 0.0 109.294 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.851 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 1.3 m 73.24 74.16 0.13 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.277 -0.889 . . . . 0.0 109.509 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' BH2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.518 ' HA3' ' CZ ' ' A' ' 7' ' ' PHE . . . -109.0 117.22 4.87 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -138.16 117.89 13.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.219 -1.165 . . . . 0.0 109.595 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.472 ' N ' ' SG ' ' A' ' 1' ' ' CYS . 33.9 mtpt . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.417 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LSP . . . . . 0.798 ' HN3' ' HB2' ' A' ' 5' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 7.1 t . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.245 0.545 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.418 ' C ' ' OXT' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -116.24 161.99 18.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.319 -0.863 . . . . 0.0 109.31 179.896 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.68 ' O ' ' HB2' ' A' ' 4' ' ' DAL . 6.7 pt20 -134.96 101.01 4.75 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.228 -0.92 . . . . 0.0 109.593 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' DAL . . . . . 0.68 ' HB2' ' O ' ' A' ' 3' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.426 ' HB2' ' HG3' ' A' ' 11' ' ' DBB . 0.0 OUTLIER -75.42 106.98 7.24 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.258 -0.901 . . . . 0.0 109.237 179.894 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . . . -99.94 -45.5 5.67 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.201 -0.937 . . . . 0.0 109.672 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.549 ' O ' ' CG ' ' A' ' 7' ' ' PHE . 35.5 p90 -135.33 116.78 14.71 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.226 -0.921 . . . . 0.0 109.447 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -169.82 173.26 43.97 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.0 -34.7 1.61 Allowed 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.599 2.199 . . . . 0.0 110.315 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -100.0 -83.64 0.43 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.196 -0.94 . . . . 0.0 109.255 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' DBB . . . . . 0.426 ' HG3' ' HB2' ' A' ' 5' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.485 ' CE1' HG23 ' A' ' 13' ' ' VAL . 2.1 p90 -140.52 12.45 2.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.956 -1.09 . . . . 0.0 109.189 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.841 HG21 ' H2 ' ' A' ' 100' ' ' LSP . 80.8 t -114.42 107.72 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.285 -0.884 . . . . 0.0 109.33 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.468 ' SG ' ' O ' ' A' ' 3' ' ' GLN . 0.0 OUTLIER -58.58 151.48 20.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.426 -0.797 . . . . 0.0 109.523 -179.796 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' BH2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.41 ' O ' ' CB ' ' A' ' 3' ' ' GLN . . . 150.47 -131.67 3.66 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -110.34 143.23 40.87 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.274 -1.133 . . . . 0.0 109.575 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.491 ' NZ ' ' CB ' ' A' ' 19' ' ' LYS . 7.4 mtpm? . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 117.987 -1.006 . . . . 0.0 109.486 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LSP . . . . . 0.841 ' H2 ' HG21 ' A' ' 13' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.465 ' O ' ' HG2' ' A' ' 3' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.418 ' CD ' ' H ' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -66.69 120.22 13.12 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.206 -0.934 . . . . 0.0 108.843 179.64 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.702 ' O ' ' HB2' ' A' ' 4' ' ' DAL . 1.2 mt-30 -125.66 91.56 3.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.183 -0.948 . . . . 0.0 109.866 -179.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' DAL . . . . . 0.702 ' HB2' ' O ' ' A' ' 3' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.859 ' HB2' ' HA ' ' A' ' 14' ' ' CYS . 23.6 t 75.03 84.48 0.1 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.252 -0.905 . . . . 0.0 109.111 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . . . -107.02 -34.24 7.24 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.288 -0.883 . . . . 0.0 109.739 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.548 ' CE2' H111 ' A' ' 100' ' ' LSP . 48.5 p90 -104.64 30.78 5.16 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.113 -0.992 . . . . 0.0 109.684 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -103.45 145.38 16.18 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -76.75 -12.54 18.15 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.434 2.089 . . . . 0.0 110.3 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -109.0 -72.65 0.72 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.126 -0.984 . . . . 0.0 109.058 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.432 ' CD1' ' C ' ' A' ' 12' ' ' PHE . 13.8 p90 -127.42 -29.65 2.68 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.124 -0.985 . . . . 0.0 109.627 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.59 ' O ' ' HB2' ' A' ' 14' ' ' CYS . 96.8 t -60.7 -56.37 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.168 -0.957 . . . . 0.0 109.593 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.859 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 0.0 OUTLIER 77.73 79.36 0.07 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.507 -0.746 . . . . 0.0 109.42 -179.793 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' BH2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.512 ' O ' ' HB3' ' A' ' 3' ' ' GLN . . . -82.01 143.27 23.0 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -141.4 68.17 1.34 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.09 -1.241 . . . . 0.0 109.703 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.033 -1.042 . . . . 0.0 109.394 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LSP . . . . . 0.548 H111 ' CE2' ' A' ' 7' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.439 ' SG ' ' ND2' ' A' ' 17' ' ' ASN . 1.5 p . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.32 0.581 . . . . 0.0 109.502 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.498 ' HD3' ' N ' ' A' ' 2' ' ' ARG . 0.0 OUTLIER -104.75 142.77 34.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.288 -0.882 . . . . 0.0 109.061 179.849 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.721 ' O ' ' HB2' ' A' ' 4' ' ' DAL . 0.0 OUTLIER -140.23 114.74 9.35 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.178 -0.951 . . . . 0.0 109.842 -179.827 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' DAL . . . . . 0.864 ' O ' ' HB3' ' A' ' 5' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.864 ' HB3' ' O ' ' A' ' 4' ' ' DAL . 15.9 t 75.08 111.82 0.07 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.194 -0.941 . . . . 0.0 109.8 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . . . -120.61 -33.11 3.89 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.327 -0.858 . . . . 0.0 109.313 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.488 ' CD1' H111 ' A' ' 100' ' ' LSP . 2.2 p90 -118.48 45.35 2.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.262 -0.899 . . . . 0.0 109.462 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.416 ' HA2' H112 ' A' ' 100' ' ' LSP . . . -104.13 158.41 16.8 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.52 -18.45 13.75 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.544 2.163 . . . . 0.0 110.418 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -113.16 -67.25 1.01 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.285 -0.884 . . . . 0.0 109.32 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -113.54 -25.58 8.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.034 -1.041 . . . . 0.0 109.563 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.596 HG21 ' H2 ' ' A' ' 100' ' ' LSP . 2.7 t -53.66 -31.78 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.275 -0.891 . . . . 0.0 109.323 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.695 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 0.9 OUTLIER 53.38 71.72 0.48 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.355 -0.84 . . . . 0.0 109.634 179.785 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' BH2 . . . . . 0.452 ' HB ' H122 ' A' ' 100' ' ' LSP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.493 ' O ' ' HB3' ' A' ' 3' ' ' GLN . . . -176.74 -170.5 39.34 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.439 ' ND2' ' SG ' ' A' ' 1' ' ' CYS . 26.5 t30 -140.19 141.21 35.99 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.175 -1.191 . . . . 0.0 109.72 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 3' ' ' GLN . 6.2 mtmt . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 118.028 -0.986 . . . . 0.0 109.532 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LSP . . . . . 0.596 ' H2 ' HG21 ' A' ' 13' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.411 ' C ' ' HG3' ' A' ' 2' ' ' ARG . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.288 0.566 . . . . 0.0 109.495 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.451 ' O ' ' HG3' ' A' ' 19' ' ' LYS . 7.2 mtm180 -142.47 95.02 2.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -0.901 . . . . 0.0 109.259 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.75 ' HB2' ' H ' ' A' ' 18' ' ' DBB . 1.4 tt0 -99.52 62.04 1.2 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.063 -1.023 . . . . 0.0 109.244 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' DAL . . . . . 0.811 ' O ' ' HB3' ' A' ' 5' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.811 ' HB3' ' O ' ' A' ' 4' ' ' DAL . 44.3 t 79.33 73.24 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.536 -0.727 . . . . 0.0 109.435 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . . . -108.99 2.19 21.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.299 -0.876 . . . . 0.0 109.615 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.452 ' CD1' ' C ' ' A' ' 7' ' ' PHE . 8.7 p90 -125.61 -14.12 6.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.112 -0.992 . . . . 0.0 109.912 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -67.2 162.37 46.73 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.18 -19.31 12.13 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.582 2.188 . . . . 0.0 110.519 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -106.64 -86.64 0.48 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.214 -0.929 . . . . 0.0 109.613 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 27.4 p90 -128.34 8.07 5.96 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.62 -1.3 . . . . 0.0 110.196 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.914 HG21 ' H12' ' A' ' 100' ' ' LSP . 40.6 t -95.21 -43.79 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.173 -0.954 . . . . 0.0 109.362 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.788 ' H ' ' HB2' ' A' ' 5' ' ' CYS . 0.5 OUTLIER 72.77 125.91 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.229 -0.92 . . . . 0.0 109.452 179.891 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' BH2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 3' ' ' GLN . . . 169.93 -137.05 4.28 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -139.1 143.26 38.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.248 -1.148 . . . . 0.0 109.291 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' DBB . . . . . 0.75 ' H ' ' HB2' ' A' ' 3' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.487 ' HG3' ' HA ' ' A' ' 3' ' ' GLN . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.078 -1.014 . . . . 0.0 109.446 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LSP . . . . . 0.914 ' H12' HG21 ' A' ' 13' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 26.7 p . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.523 ' HB2' ' CD ' ' A' ' 19' ' ' LYS . 2.6 mmp_? -102.52 137.13 41.16 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.162 -0.961 . . . . 0.0 109.717 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.691 ' O ' ' HB2' ' A' ' 4' ' ' DAL . 0.0 OUTLIER -119.83 60.09 0.86 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.409 -0.807 . . . . 0.0 109.407 -179.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' DAL . . . . . 0.775 ' O ' ' HB3' ' A' ' 5' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.775 ' HB3' ' O ' ' A' ' 4' ' ' DAL . 36.3 t 73.88 91.74 0.08 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.336 -0.853 . . . . 0.0 109.546 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . . . -118.93 -5.35 10.58 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.193 -0.942 . . . . 0.0 109.714 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.406 ' CZ ' ' HA2' ' A' ' 16' ' ' GLY . 14.5 p90 -129.52 19.02 5.75 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.161 -0.962 . . . . 0.0 109.727 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.403 ' H ' ' HG1' ' A' ' 11' ' ' DBB . . . -93.28 162.45 25.88 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.32 -21.03 10.71 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.689 2.259 . . . . 0.0 110.573 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -105.48 -54.58 2.46 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.111 -0.993 . . . . 0.0 109.792 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' DBB . . . . . 0.403 ' HG1' ' H ' ' A' ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -100.9 -10.33 20.75 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.185 -0.947 . . . . 0.0 109.628 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.592 HG21 ' H2 ' ' A' ' 100' ' ' LSP . 11.5 t -70.88 -23.42 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.26 -0.9 . . . . 0.0 109.333 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.729 ' CA ' ' HB2' ' A' ' 5' ' ' CYS . 0.0 OUTLIER 43.66 65.04 1.08 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.394 -0.816 . . . . 0.0 110.015 -179.911 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' BH2 . . . . . 0.46 ' O ' ' OB ' ' A' ' 15' ' ' BH2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.406 ' HA2' ' CZ ' ' A' ' 7' ' ' PHE . . . -154.89 124.07 1.46 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.473 ' O ' ' HG3' ' A' ' 18' ' ' DBB . 0.1 OUTLIER -121.36 34.84 5.06 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.35 -1.088 . . . . 0.0 109.305 179.715 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' DBB . . . . . 0.473 ' HG3' ' O ' ' A' ' 17' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.523 ' CD ' ' HB2' ' A' ' 2' ' ' ARG . 7.8 mtpp . . . . . 0 N--CA 1.49 1.554 0 O-C-N 120.967 -1.083 . . . . 0.0 109.536 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LSP . . . . . 0.592 ' H2 ' HG21 ' A' ' 13' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 15.8 p . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 121.359 0.6 . . . . 0.0 109.439 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.429 ' O ' ' C ' ' A' ' 19' ' ' LYS . 2.7 mmp_? -78.3 141.45 38.48 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.22 -0.925 . . . . 0.0 109.341 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.684 ' O ' ' HB2' ' A' ' 4' ' ' DAL . 0.4 OUTLIER -138.84 103.64 4.87 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.312 -0.867 . . . . 0.0 109.463 -179.769 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' DAL . . . . . 0.684 ' HB2' ' O ' ' A' ' 3' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.863 ' HB3' ' HA ' ' A' ' 14' ' ' CYS . 0.5 OUTLIER 75.65 111.1 0.07 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.153 -0.967 . . . . 0.0 109.184 -179.646 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.406 ' CB ' ' HB2' ' A' ' 19' ' ' LYS . . . -119.84 -25.96 5.74 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.156 -0.965 . . . . 0.0 109.579 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -128.72 66.97 1.4 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.195 -0.941 . . . . 0.0 109.718 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -120.66 174.15 15.64 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.2 -19.13 12.24 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.693 2.262 . . . . 0.0 110.396 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -134.8 -55.58 0.83 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.284 -0.885 . . . . 0.0 109.39 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -116.34 -21.06 9.47 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.145 -0.972 . . . . 0.0 109.648 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.535 HG21 ' H2 ' ' A' ' 100' ' ' LSP . 74.4 t -61.2 -49.66 83.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.167 -0.958 . . . . 0.0 109.257 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.863 ' HA ' ' HB3' ' A' ' 5' ' ' CYS . 0.0 OUTLIER 69.49 45.9 0.78 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.361 -0.837 . . . . 0.0 109.948 179.685 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' BH2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -106.87 159.47 14.72 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -133.38 126.9 32.29 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.227 -1.161 . . . . 0.0 109.45 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' DBB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 2' ' ' ARG . 6.1 mtmp? . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 117.947 -1.025 . . . . 0.0 109.552 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LSP . . . . . 0.535 ' H2 ' HG21 ' A' ' 13' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.449 ' O ' ' OXT' ' A' ' 19' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 12.9 mtm180 57.36 -167.27 0.13 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.218 -0.926 . . . . 0.0 109.003 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.678 ' O ' ' HB2' ' A' ' 4' ' ' DAL . 0.8 OUTLIER -139.55 111.42 7.34 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.095 -1.003 . . . . 0.0 109.739 -179.755 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' DAL . . . . . 0.678 ' HB2' ' O ' ' A' ' 3' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.59 ' HB3' ' O ' ' A' ' 11' ' ' DBB . 51.1 t -68.16 108.9 3.32 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.224 -0.922 . . . . 0.0 109.593 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . . . -102.04 -58.01 1.96 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.191 -0.943 . . . . 0.0 109.512 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -119.11 132.68 56.02 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.278 -0.889 . . . . 0.0 109.468 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.97 167.71 22.81 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.426 -1.469 . . . . 0.0 109.426 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.03 -10.1 17.97 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.616 2.211 . . . . 0.0 110.401 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -106.05 -90.43 0.42 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.243 -0.91 . . . . 0.0 109.419 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' DBB . . . . . 0.59 ' O ' ' HB3' ' A' ' 5' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -139.94 37.45 1.96 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.125 -0.985 . . . . 0.0 109.523 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.801 HG11 ' O21' ' A' ' 100' ' ' LSP . 16.6 t -121.64 -13.67 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.154 -0.966 . . . . 0.0 109.676 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.532 ' H ' ' HB2' ' A' ' 5' ' ' CYS . 0.0 OUTLIER 60.77 147.73 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.198 -0.939 . . . . 0.0 109.078 -179.755 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' BH2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 170.89 -155.05 23.99 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.407 ' ND2' ' HG3' ' A' ' 18' ' ' DBB . 12.0 t30 -102.09 149.95 23.74 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.382 -1.069 . . . . 0.0 109.526 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' DBB . . . . . 0.407 ' HG3' ' ND2' ' A' ' 17' ' ' ASN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.449 ' OXT' ' O ' ' A' ' 1' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 117.908 -1.044 . . . . 0.0 109.587 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LSP . . . . . 0.801 ' O21' HG11 ' A' ' 13' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_